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Body of Abstract
Central chemoreception is the mechanism by which the brain regulates breathing in response to changes
in tissue pH/CO2. It is particularly important during sleep and its disruption has been associated with
certain pathologies, including central sleep apnea and central congenital hypoventilation syndrome. A
region of the brainstem called the retrotrapezoid nucleus (RTN) is thought to be an important site of
central chemoreception.

Recent evidence suggests that RTN chemoreception involves two mechanisms. The first appears to be H+mediated activation of neurons via inhibition of pH-sensitive potassium channels. More recently, a second
sensing mechanism has been identified; paracrine release of ATP in the RTN region that acts on P2
receptors. It has been postulated that astrocytes in the region release ATP, as they have been found to
release ATP in other brain regions in response to various stimuli. However, the mechanisms by which
astrocytes sense CO2 and/or pH are not known.

Astrocytes in many brain regions are known to express Kir4.1 and/or Kir4.1-Kir5.1 potassium channels,
which are highly pH sensitive. In addition, Kir4.1-Kir5.1 is expressed in the RTN. I hypothesize that RTN
astrocyte sense CO2/H+ by inhibition of Kir4.1-Kir5.1 channels, which results in membrane
depolarization. I also hypothesize that ATP released via connexin hemichannels in response to CO2/H+
acts on P2-receptors on RTN neurons to increase neuronal action potential firing, and that this purinergic
mechanism of chemoreception is restricted to the ventral surface, affecting primarily RTN neurons. The
evidence described in this thesis supports four main conclusions; (1) Kir4.1/Kir5.1 channels, and the
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sodium bicarbonate cotratransporter, are the mechanism of RTN astrocyte chemosensitivity, (2) CO2driven purinergic signaling in the RTN is required for complete chemosensation in vivo and in vitro, (3)
CO2-evoked ATP release is dependent on connexin hemichannels and (4) these purinergic mechanisms
are specific to the RTN.

ii

The Role of Astrocyte and Purinergic Signaling in RTN Chemoreception

Ian Christopher Wenker

B.S. Xavier University, 2005
M.S. Wright State University, 2009

A Dissertation
Submitted in Partial Fulfillment of the
Requirements for the Degree of Doctor of Philosophy
at the
University of Connecticut
2014

iii

Copyright by
Ian Christopher Wenker

2014

iv

Approval Page

Doctor of Philosophy Dissertation
The Role of Astrocyte and Purinergic Signaling in RTN Chemoreception

Presented by
Ian Christopher Wenker, B.S., M.S.

Major Advisor _______________________________________________________________________
Daniel K. Mulkey

Associate Advisor_____________________________________________________________________
Anastasios V. Tzingounis

Associate Advisor_____________________________________________________________________
Akiko Nishiyama

University of Connecticut
2014
v

Acknowledgements
To thank all of those who have helped me over the past five year would be impossible. Thus, I would like
to acknowledge the main contributors to my PhD work. First, I believe I must thank our collaborators at
the University of Sao Paulo, who ran the in vivo experiments. This includes Dr. Thiago Moreira, Dr. Ana
Takakura and Cleyton Sobrinho. The latter deserves special recognition, since he not only did many
experiments, but also gave me shelter, and delicious food, in Sao Paulo while I was learning about their in
vivo techniques. I would like to thank Dr. Andrew Moiseff and Ed Lechowicz. Although the project that
you both helped me with is not in this thesis, it was both fun and educational to tackle an engineering
problem with you two. A number of students, past and present, have aided me in my research, most
notably Dr. Robert Hill, whose patience with my unending questions about immunohistochemistry and
imaging was commendable. My committee members deserve special thanks. Although we did not have
many formal meetings, each one of you has supported me at some point during my studies. In my early
graduate school days, Dr. Nishiyama helped me to become a mediocre immunohistochemistic, which is
quite an accomplishment, believe me. And when the federal government is shut down Dr. Tzingounis
makes a terrific offline Pubmed. Finally, I cannot forget the man who convinced me to move to a more
rural and colder locale than my home town; Dr. Daniel Mulkey. All kidding aside, he has encouraged me
to apply for grants, present at meetings and explore my interests, and at the same time helped me build
quite a resume. It is amazing how much I have been able to develop as a scientist, and it is due to the
support of those I have mentioned and many more!

vi

Dedication
I would like to dedicate this thesis to my beautiful wife Jelena.

vii

Table of Contents

Abstract .......................................................................................................................................................... i
Copyright ..................................................................................................................................................... iv
Approval ....................................................................................................................................................... v
Acknowledgements ...................................................................................................................................... vi
Dedication ................................................................................................................................................... vii
Table of Contents ....................................................................................................................................... viii
List of Figures ............................................................................................................................................... x
Chapter 1 Introduction .................................................................................................................................. 1
Chapter 2 Background and Literature Review .............................................................................................. 3
CENTRAL RESPIRATORY CHEMORECEPTION............................................................................... 3
PURINERGIC SIGNALING .................................................................................................................... 7
GLIAL CELLS ....................................................................................................................................... 10
Chapter 3 Hypothesis and Specific Aims ................................................................................................... 12
Chapter 4 Astrocyte of the Retrotrapezoid Nucleus Sense H+ by Inhibition of a Kir4.1-Kir5.1-like
Current and May Contribute to Chemoreception by a Purinergic Mechanism ........................................... 14
INTRODUCTION .................................................................................................................................. 14
METHODS ............................................................................................................................................. 15
RESULTS ............................................................................................................................................... 18
DISCUSSION ......................................................................................................................................... 37
Chapter 5 Regulation of Ventral Surface CO2/H+-sensitive neurons by purinergic signaling .................. 42
INTRODUCTION .................................................................................................................................. 42
METHODS ............................................................................................................................................. 44
RESULTS ............................................................................................................................................... 48
DISCUSSION ......................................................................................................................................... 68
Chapter 6 Purinergic signaling contributes to chemoreception at the level of the retrotrapezoid neucleus
but not the nucleus of the solitary tract or medullary raphe. ....................................................................... 78
INTRODUCTION .................................................................................................................................. 78
METHODS ............................................................................................................................................. 80
RESULTS ............................................................................................................................................... 84
DISCUSSION ....................................................................................................................................... 105
Chapter 7 Summary of Major Findings .................................................................................................... 112

viii

Chapter 8 Literature Cited ........................................................................................................................ 117
Chapter 9 Curriculum Vitae ...................................................................................................................... 131

ix

List of Figures
Figure 1 ....................................................................................................................................................... 19
Figure 2 ....................................................................................................................................................... 22
Figure 3 ....................................................................................................................................................... 25
Figure 4 ....................................................................................................................................................... 29
Figure 5 ....................................................................................................................................................... 32
Figure 6 ....................................................................................................................................................... 35
Figure 7 ....................................................................................................................................................... 50
Figure 8 ....................................................................................................................................................... 53
Figure 9 ....................................................................................................................................................... 56
Figure 10 ..................................................................................................................................................... 59
Figure 11 ..................................................................................................................................................... 61
Figure 12 ..................................................................................................................................................... 64
Figure 13 ..................................................................................................................................................... 66
Figure 14 ..................................................................................................................................................... 69
Figure 15 ..................................................................................................................................................... 71
Figure 16 ..................................................................................................................................................... 87
Figure 17 ..................................................................................................................................................... 90
Figure 18 ..................................................................................................................................................... 92
Figure 19 ..................................................................................................................................................... 95
Figure 20 ..................................................................................................................................................... 98
Figure 21 ................................................................................................................................................... 101
Figure 22 ................................................................................................................................................... 103
Figure 23 ................................................................................................................................................... 106

x

Chapter 1 Introduction
Breathing is a physiological phenomenon that begins at birth and continues, relatively uninterrupted, until
the end of life. For terrestrial animals, like humans, breathing occurs by moving air in and out of the
lungs. The much needed oxygen (O2) diffuses into the blood via the pulmonary epithelial cells, and the
waste product, carbon dioxide (CO2), likewise diffuses out.
The drive to breathe must adjust to metabolic demand, with increases occurring during activities like
exercise or holding one’s breath. This drive to breathe is even present during periods of relaxation or
sleep, as is evident by our continuous respiratory activity. Conversely, disruption of the drive to breathe is
thought to be a cause of death for people with certain pathologies, including epilepsy and stroke (Davis,
Billings et al. 2013, Richerson, Buchanan 2011). In other cases compromised respiratory drive does not
lead to death, but severely impacts quality of life. Such is the case in central congenital hypoventilation
syndrome and the more common sleep apnea (Shea 1997, Dempsey, Smith et al. 2012).
Central chemoreception is the homeostatic process by which the central nervous system senses CO2 in
order to adequately maintain O2/CO2 levels and is a major component of respiratory drive. Although the
study of central chemoreception dates back at least half a century, it’s cellular and molecular mechanism
remains incompletely understood. Better understanding of these mechanisms could lead to new therapies
to improve the quality of life for people afflicted with the aforementioned diseases.
In addition, I would like to point out another important reason for the study of central chemoreception,
breathing and autonomic behaviors in general. We are in the advent of modern neuroscience.

Today

the neuroscience community is, more than ever, discussing the best ways to understand how the brain
functions at every level. The new funding mechanisms the B.R.A.I.N. initiative in the United States and
the Human Brain Project in the European Union, that essentially wants to create the human brain in silico,
we are dreaming bigger than ever before. I have no doubt that the advances in the 21st century will be
astounding. However, we are still just beginning this quest. Compared to other organ systems very little is
1

known about the human brain. I propose that the study of basic physiological processes, like breathing, is
an excellent place to begin to fully understand the brain’s function. The respiratory control system of the
pons and medulla contains many of the hallmark characteristics of neural circuits; including gain control,
conditioning, spontaneous and oscillatory components, neurmodulation and plasticity.

Furthermore,

whereas other brain phenomena like anxiety, learning and memory, or compassion can be difficult to
measure; respiratory output is easily measured and quantified, meaning greater certainty in results. In
summary, while self-awareness and memory are exciting brain functions in need of study, let us not forget
that homeostatic behaviors, like breathing, offer a chance to study the complexity of neural circuits, with
more quantitative behavioral readouts.

2

Chapter 2 Background and Literature Review

CENTRAL RESPIRATORY CHEMORECEPTION

Ventilation (also referred to herein as respiration or breathing) is the process an organism goes through to
achieve adequate gas exchange. For animals the main function of ventilation is to absorb the molecular
substrate for cellular respiration (i.e. O2) and release the byproduct (i.e. CO2). In the vast majority of
mammals this is called “breathing” and is accomplished through the epithelium of the lungs. Air is moved
into the lungs via negative pressure produced by contraction of the diaphragm muscle, and expelled
passively when the diaphragm relaxes. Thus breathing requires alternating periods of diaphragm
contraction and relaxation, and this continues, relatively uninterrupted, from birth until death.
Unlike the heart, the lungs have no intrinsic pacemaker cells. The rhythm of diaphragm contraction is
controlled from the central nervous system. It is commonly accepted that the mammalian respiratory
pattern generator (rCPG) is located in the Prebotzinger complex of the ventrolateral medulla (Smith,
Ellenberger et al. 1991). This nucleus contains inspiratory and pre-inspiratory neurons that project,
polysynaptically via premotor neurons, to respiratory motor neurons. Phrenic motor neurons receive
indirect Prebotzinger input, causing them to oscillate between periods of high activity and quiescence.
Thus their synaptic connections to the diaphragm translate the activity of the rCPG into physical
ventilatory motor activity that we call breathing.
Respiratory rhythm is labile; increasing or decreasing depending on the metabolic demand. There are
many homeostatic mechanisms that exist to match ventilation to metabolic demand. In the lungs there are
mechano-, and irritant-, receptors that respond to lung stretch and irritants, respectively, and feedback via
the brainstem to alter the respiratory rhythm (Pisarri, Jonzon et al. 1990). In the peripheral vasculature
there are specialized organs (i.e. the aortic and carotid bodies) that sense changes in blood gases and also
feedback to the brainstem to adjust the respiratory rhythm (O'Regan, Majcherczyk 1982). Finally, the
respiratory centers in the brainstem receive input from higher brain centers, including the pons,
3

hypothalamus and cortex which drive breathing, and are thought to coordinate breathing changes needed
for subconscious activities like the fear response and higher order processes like talking or singing.
Respiratory chemosensation (hereafter referred to as simply “chemoreception”), the sensation and
regulation of CO2/O2 levels in the body, is a major homeostatic mechanism of respiration. Disruption of
chemoreception is thought to result in a number of breathing disorders, including central congenital
hypoventilation syndrome (CCHS) and central sleep apnea (Weese-Mayer, Berry-Kravis et al. 2003,
Collop 2009). Initially it was thought that the cellular components of chemoreception resided solely in the
central nervous system (O'Regan, Majcherczyk 1982). It was subsequently found that the carotid and
aortic bodies (now known as peripheral chemoreceptors), were capable of mediated respiratory responses
to altered O2/CO2 levels (Heymans, Bouckaert 1930).

However, it was also observed that CO2

chemoreception persisted even in the absence of functional carotid and aortic bodies (O'Regan,
Majcherczyk 1982). The phenomenon of central CO2 chemoreception was later confirmed in the 1950’s
when Leusen and colleagues used the ventricle perfusion technique to selectively reduce pH in the central
nervous system, and observed increased ventilation (Leusen 1954). Thus it is understood that there are
both central and peripheral chemoreceptors, the former being the focus of this thesis.
Probably because of anatomical distinction, carotid and aortic bodies were identified as peripheral
chemoreceptors in the early part of the 20th century, which won Corneille Heymans the Nobel Prize in
1938. On the other hand, the identity of central chemoreceptors was, and to a certain extent remains,
elusive (Guyenet, Bayliss et al. 2009, Nattie, Li 2008). In the 1960’s Loeschcke and colleagues began to
search for central chemoreceptors in the ventral medulla. They found that acidic solution applied to
certain areas of the ventral lateral medulla (VLM) increased ventilation (Mitchell, Loeschcke et al. 1963,
Loeschcke 1982). These data led to the hypothesis that central chemoreceptor cells resided in particular
regions of the VLM.

4

By the late 1980’s the practice of brain slice electrophysiology to study neuroscience phenomena was in
full swing, and the field of chemoreception was no exception. Finding brain regions that appeared to
contribute to chemoreception was now not enough, and the new search was for chemoreceptor neurons.
One of the first regions found to contain chemosensitive neurons was the nucleus of the solitary tract
(NTS). The NTS is located in the dorsal medulla, opposite from chemosensitive regions (i.e. the VLM)
identified decades before. In 1989, Millhorn and colleagues identified neurons in the commissural NTS
(cNTS) that varied their action potential firing frequency in response to changes in CO 2/H+ (Dean,
Lawing et al. 1989). Most CO2-sensitive neurons increased action potential firing when exposed to
elevated CO2 in the Ringers solution. It was also found that the CO2-sensitivity was not dependent on
synaptic input, indicating this was an intrinsic response of the neuron (Dean, Bayliss et al. 1990). To this
day the neuronal cell type and CO2 sensing mechanism in the NTS have eluded researchers.
The next region of the medulla found to house chemosensitive neurons was that of the medullary and
midbrain raphe. The medullary raphe is the main grouping of serotonergic neurons in the hindbrain. In
1995 George Richerson observed CO2/H+-sensitive neurons in the medullary raphe, and identified them
as serotonergic (Wang, Tiwari et al. 2001, Richerson 1995). Later, those of the midbrain were found to be
CO2-sensitive as well (Severson, Wang et al. 2003). In addition, the mechanism of CO2 sensing was for
the midbrain raphe chemosensitive neurons was found to be pH-sensitive TASK3 (twik-related acidsensitive potassium channels isoform 3 or K2P9.1), although the ablation of TASK3 had no effect on
whole animal CO2 chemosensitivity (Mulkey, Talley et al. 2007), suggesting that although raphe neurons
are chemosensitive, they are not major contributors to respiratory chemoreception. More recent studies,
however, have provided evidence for a medullary serotonergic raphe neuronal role in central
chemoreception. Dual use of Cre and Flpe receombinase systems have allowed for specific expression of
DREADD receptors in rostral medullary raphe neurons (Armbruster, Li et al. 2007). When exposed to the
exogenous ligand clozapine-N-oxide (CNO), DREADD (Designer Receptors Exclusively Activated by
Designer Drugs) receptors hyperpolarize the cell membrane, thus silencing neuronal firing of action
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potentials. Using this paradigm, the authors observed reduced CO2 chemoreception in vivo when the
rostral medullary serotonergic raphe neurons were inhibited (Ray, Corcoran et al. 2011).
In 2004 chemosensitive neurons were identified in a region that roughly corresponded to those identified
by Loeschcke and colleagues in 1960’s, as evident in the editorial “Back to the future: carbon dioxide
cheomoreceptors in the mammalian brain” (Mitchell 2004). Mulkey and colleagues identified
chemosensitive neurons in the rostral VLM, more specifically in a region of the brain called the
retrotrapezoid nucleus, or RTN (Mulkey, Stornetta et al. 2004). The RTN was identified years before, in
both cats and rats, as a region with major inputs into major respiratory centers of the medulla (Smith,
Morrison et al. 1989, Pearce, Stornetta et al. 1989). In the study by Mulkey in 2004, and following work,
the authors found that a subset of neurons in the RTN show increased action potential firing during
elevated CO2/H+, and this is not due to synaptic, carotid body or respiratory CPG input (Mulkey, Stornetta
et al. 2004). The chemosensitive RTN neurons are glutamatergic, project to major respiratory regions and
express the transcription factor Phox2b (Mulkey, Stornetta et al. 2004, Stornetta, Moreira et al. 2006).
Phox2b is a transcription fact that, when mutated in humans and mice, results in a near complete loss of
chemoreception (Weese-Mayer, Berry-Kravis et al. 2003, Amiel, Dubreuil et al. 2009). In addition to
dysfunctional chemoreception, mutations of Phox2b in mice resulted in the absence of chemoreceptor
RTN neurons (Amiel, Dubreuil et al. 2009). More evidence of a role for RTN neurons in central
chemoreception include; specific activation of Phox2b RTN neurons with channelrhodpsin2 results in
cardio and ventilatory responses that are similar to those during hypercapnia, and when Phox2b RTN
neurons are ablated using selective toxins decreased chemoreception is observed (Takakura, Moreira et al.
2008, Marina, Abdala et al. 2010, Abbott, Stornetta et al. 2009).
As apparent from above, there is range of evidence for a number of medullary regions and cell types (i.e.
cNTS, medullary Raphe and RTN) to be involved in central chemoreception. The description here does
not detail the work of Nattie and colleagues, who, using microdialysis of CO2/H+ into the medulla have
determined a number regions (including those mentioned above) that appear to contribute to
6

chemoreception (Nattie, Li 2008). These observations have led to the “distributed theory” of central
chemoreception, in which there are multiple neuronal groups that are sensitive to CO2/H+ and activate the
respiratory system. The reason for multiple neuronal types with the same function is not clear, although
the common response is “redundancy” (Nattie, Li 2008). Redundancy is the concept that important
functions, like respiratory control, will have backups in case one becomes nonfunctional. This certainly
appeals to logic. Yet, destruction of even a small number of these neurons in the Prebotzinger complex,
the group of neurons necessary for respiratory rhythm to be generated (Tan, Janczewski et al. 2008),
results in a loss of respiratory motor activity (Hayes, Wang et al. 2012). Even with a system so
susceptible to small amounts of cell death breathing continues. An alternative view could be that each
chemosensitive neuronal population contributes to central chemoreception in its own way. For instance,
medullary raphe chemosensitive neurons could modulate behavior of the respiratory system (e.g. they are
serotonergic and serotonin is a common neuromodulator), RTN neurons could provide more tonic
excitatory input to the system (e.g. they are glutamtergic) and NTS neurons may effect peripheral
autonomic reflexes (e.g. they are located in the major visceral relay center of the medulla). In any case,
direct evidence to indicate a single chemoreceptor site is lacking. This would require specific ablation of
the CO2/H+-sensing mechanism in a particular set of cells, while preserving all other function of those
cells. This would likely be accomplished by using transgenic approaches to eliminate CO2/H+-sensing
mechanisms in specific cell populations. To begin to construct such transgenic experiments we must first
determine the cellular identity and sensing mechanisms of particular chemoreceptors cells. As such, in
this thesis I have focused on determining CO2/H+-sensing mechanisms of RTN chemoreceptor neurons
and astrocytes.

PURINERGIC SIGNALING
Adenosine tri-phosphate, ATP, a purine nucleotide, is an important player in molecular biology. Most
notably ATP is the “molecular currency” of energy transfer within a cell. Much of the study of
biochemistry is concerned with its synthesis and metabolism. ATP is generated during glycolysis,
7

photosynthesis and cellular respiration and the energy stored in the three phosphate bonds can be used for
many cellular functions. For instance, transmembrane pumps, such as the Na-K-ATPase, use the energy
stored in the phosphate bonds of ATP to move molecules against their electrochemical gradient.
Intracellular signaling pathways utilize ATP as a substrate by kinases that phosphorylate proteins and
lipids, and by adenylate cyclase, which produces the second messenger molecule, cyclic AMP. More
recently ATP has been found to be involved in intercellular signaling, acting in autocrine, paracrine and
neurocrine mechanisms on membrane bound purinergic receptors (Burnstock 2007).
Perhaps due to the fact that ATP is such an important molecule for cell metabolism it was difficult for the
scientific community to accept that it was involved in intercellular signaling. The first observation that
ATP can act extracellularly occurred during experiments on cardiac tissue in 1929 (Drury, Szent-Gyorgyi
1929). Later it was found to act in the intestine and parts of the spinal cord (Buchthal, Engbaek 1947,
Gillespie 1934). Exogenous ATP acts as an antagonist to certain anesthetics and is released from nerve
axons (Kuperman, Okamoto et al. 1964, Kuperman, Volpert et al. 1964). In 1970 Geoffrey Burnstock
postulated that ATP is used for specific intercellular signaling (Burnstock, Campbell et al. 1970). He
discovered nerves in the autonomic nervous system innervating the gut and bladder that utilized ATP as
their neurotransmitter. Since then ATP has been described as a neurotransmitter in the autonomic, central
and nociceptive nervous systems and is a cotransmitter in many other regions (Burnstock 2007).
The membrane receptors whose ligands are purines and pyrimidines are commonly referred to as
purinergic receptors. There are at least three different families of purinergic receptors; P1 (also referred
to as adenosine receptors), P2X and P2Y receptors. Purinergic receptors have been found to be located in
many regions of the body and function in an equally wide array of cellular processes.
P1 receptors are G-protein coupled receptors. There are four P1 receptor subtypes; A1, A2A, A2B and
A3, which all respond to adenosine as their endogenous agonist. When A1 and A3 receptors are activated
they stimulate Gs, increasing cAMP, whereas activation of A2A and A2B receptors stimulates Gi,
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decreasing cAMP (Burnstock 2007). P1 receptor activation causes decreased heart rate, coronary
vasodilatation and A2B, in combination with neutrin-1, is involved with axon elongation in neurons
(Fredholm, IJzerman et al. 2011).
P2X receptors are ionotropic with two transmembrane domains. There are seven cloned P2X subtypes;
P2X1-7, which all respond to ATP as their endogenous agonist. P2X receptors act as cation channels and
upon activation by ATP, allow the flow of sodium, potassium and in some cases calcium. This causes
depolarization of the cell membrane, which in turn can open Ca2+ channels (Dubyak, el-Moatassim 1993).
P2X1-6 are all very similar in structure while P2X7 has an elongated intracellular peptide sequence on the
carboxy end. When exposed to ATP it initially functions as the other P2X receptors, however if the ATP
exposure is prolonged its pore enlarges and larger molecules can flow through. It is mainly expressed in
immune and glial cells, and seems to allow the release of proinflamatory cytokines (Burnstock 2008).
P2X receptors have been located in neurons, glia, bone, muscle, endothelium and hematopoietic cells
(North 2002), and have functions including fast synaptic transmission (Bardoni, Goldstein et al. 1997),
neurotransmitter release (Khakh, Henderson 1998) and pain signaling (Cockayne, Hamilton et al. 2000).
P2Y receptors are G-coupled with seven transmembrane spanning domains. There are eight P2Y receptor
subtypes that have been cloned; P2Y1, P2Y2, P2Y4, P2Y6 and P2Y11 through P2Y14 (Erb, Liao et al.
2006, Burnstock 2007). P2Y receptors respond to a more varied array of endogenous agonists, including
ATP, ADP and even uridine nucleotides UTP and UDP. The strength of response to these agonists varies
by receptor subtype, which is sometimes used for subtype identification. For instance, if a cell exhibits a
physiological response to ATP and UTP, but not ADP then the responsible receptor is likely either P2Y2
or P2Y4. G-proteins utilized by P2Y receptors are Gi, Go, Gs, Gq/G11, Gi, G12 and Gi/Go (Erb, Liao et al.
2006). Some P2Y receptor subtypes have specific G-proteins they associate with, but many can associate
with multiple. For example, the P2Y2 receptor can activate Go, Gq/G11 and G12 (Erb, Liao et al. 2006).
Stimulation of these G-proteins by recombinant P2Y receptors can either activate phospholipase C (PLC)
or adenylate cyclase, causing intracellular Ca2+ release or changes in cAMP levels, respectively. P2Y
9

signaling is responsible for numerous physiological responses (Burnstock 2007). P2Y receptors are
thought to play a role in the activation of ion channels, including the volume-regulated anion channel
(Darby, Kuzmiski et al. 2003) and of N-type Ca2+ channels (Abbracchio, Burnstock et al. 2006). P2Y
receptor expression has been shown to influence cell proliferation in a number of cell types (Bagchi, Liao
et al. 2005) and is upregulated in response to tissue injury (Ahn, Camden et al. 2000, Rohatgi, Sedehizade
et al. 2003).

GLIAL CELLS
Glial cells were discovered during the mid-19th century, not too long after Scwhann and Schleiden
theorized that all living matter was composed of cells in 1839 (Kimelberg 2004) It was Rudolf Virchow
who first coined the term neuroglia, meaning “neural-cement,” in 1856 (Ndubaku, de Bellard 2008).
Virchow’s histochemical stains illustrated clear distinctions between neurons and glia but were unable to
delineate between the different subtypes of glia. Using the black chrome-silver reaction Camillo Golgi
was the first to distinguish radial glia from other glia and neurons in 1895 (Kimelberg 2004). Ramon y
Cajal was the first to use the term “astrocyte” t describe the fibrous and protoplasmic glial subset (Somjen
1988). In 1920, Cajal’s student del Rio Hortega was able to distinguish oligodendrondrocytes and
microglia from the other two glial subsets (Somjen 1988).
Glial cells have since been split into two broader classes of macroglia and microglia, the latter being the
primary immune cell in the brain. Macroglia in the peripheral nervous system (PNS) consist of Schwann
cells and satellite cells. Schwann cells’ main role is that of axon myelination (Ndubaku, de Bellard 2008).
Satellite cells line the exterior portion of the PNS and regulate the exterior chemical environment
(Topilko 2007). Macroglia in the CNS consist of three distinct types; oligodendrocytes, polydendrocytes
and astrocytes. Similar to Schwann cells, oligodendrocytes have small somas and large end feet that are
responsible for axon myelination (Ndubaku, de Bellard 2008). Polydendrocytes, also called NG2 glia, are
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the major proliferative cell type in the adult brain, mostly giving rise to new oligodendrocytes
(Nishiyama, Komitova et al. 2009).
Astrocytes account for approximately 20-30% of brain cells in the mature CNS and are crucial for
maintaining relative homeostasis (Hertz, Zielke 2004, Kimelberg 2004). In the microenvironment
astrocytes mediate neurotransmitter and ionic homeostasis, synaptic formation, neuronal excitability and
migration, detoxification and maintenance of the blood brain barrier (Markiewicz, Lukomska 2006).
Astrocytes are thought to secrete a wide variety of neurotrophic factors, such as nerve growth factor,
NGF, and brain-derived neurotrophic factor BDNF (Villegas, Poletta et al. 2003). Astrocytes regulate the
extracellular space near synapses after high neuronal output by buffering potassium (Leis, Bekar et al.
2005, Olsen, Campbell et al. 2007) as well as neurotransmitters (Hertz, Zielke 2004).
Originally astrocytes, as well as other glial cells, were thought to simply provide neurons with structural
support, but in more recent decades it has become clear that astrocytes also are directly involved in
information processing. They are able to stabilize as well as modulate synaptic activity (Haydon, Blendy
et al. 2009). Astrocytes express many neurotransmitter receptors that, when activated, initiate calcium
signaling (Villegas, Poletta et al. 2003). These calcium waves spread between adjacent astrocytes via gap
junctions and purinergic signaling (Inoue, Koizumi et al. 2007), which can then trigger release of ATP
and glutamate; the main mediators of neuron-glia cross-talk (Villegas, Poletta et al. 2003). Astrocytes also
have been found to communicate with microglia and capillaries (Inoue, Tsuda et al. 2007), making them a
major playing or neurovascular coupling (Straub, Nelson 2007).
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Chapter 3 Hypothesis and Specific Aims
Central chemoreception is the mechanism by which the brain regulates respiration in response to changes
in tissue pH/CO2. Chemosensitivity is particularly important during sleep and its disruption has been
associated with central sleep apnea & hypoventilation syndrome (Weese-Mayer, Berry-Kravis et al. 2003,
Collop 2009). A region of the brainstem called the retrotrapezoid nucleus (RTN) is thought to be an
important site of central chemoreception (Mulkey, Stornetta et al. 2004).

Recent evidence suggests that RTN chemoreception involves two mechanisms. The first appears to be H+mediated activation of pH-sensitive neurons, via inhibition of TASK2 channels (Wang, Benamer et al.
2013). When TASK2 is ablated the CO2/H+-sensitivity of RTN neurons reduced, but not entirely ablated.
The second sensing mechanism appears to involve paracrine release of ATP that acts on neuronal P2
receptors (Gourine, Llaudet et al. 2005). Hypercapnia (elevated CO2/H+) induces ATP release at the
medullary ventral surface and pharmacological blockade of P2 receptors, or destruction of ATP by
apyrase, in this region blunts central chemoreception in vivo (Gourine, Llaudet et al. 2005). It is thought
that H+/CO2-evoked ATP release acts on P2 receptors of pH-sensitive RTN neurons. It has been
postulated that astrocytes in the region release ATP, as they have been found to release ATP in response
to various stimuli in other brain regions (Straub, Nelson 2007). However, the source and mechanisms of
this purinergic drive to breathe remains undetermined.

Hypothesis. I hypothesize that RTN astrocytes sense CO2/H+ by inhibition of Kir4.1/Kir5.1 channels,
which results in membrane depolarization. I also hypothesize that ATP released in response to CO2/H+
acts on P2-receptors expressed by RTN neurons to increase neuronal action potential firing, and that this
purinergic mechanism of chemoreception is restricted to the ventral surface, affecting primarily RTN
neurons.
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Specific Aim 1. Determine the CO2/H+-sensitive membrane properties of glial cells in the RTN.
Subsequently, identify the cell type (i.e. astrocyte, microglia etc.) and sensing mechanism (i.e. channel).
This was accomplished via patch-clamp recordings from glial cells, and post-hoc immunohistochemical
analysis of glial cell markers.

Specific Aim 2. Determine the role of P2 receptors on RTN neuronal chemosensitivity, in vivo and in
vitro. For in vitro studies, this was accomplished by making loose patch recordings from rat brain slices
of RTN neurons and measuring their response to CO2/H+ under control conditions and in the presence of
P2 antagonists. Also, I will use neuronal recordings as an assay to determine the mechanism of release by
using pharmacology to block gap junction hemichannels and inhibitors of vesicle fusion. In vivo, the
effect of P2 antagonist injection into the RTN on cardiorespiratory parameters was studied in anesthetized
adult rats.

Specific Aim 3. Determine the regional specificity of puringergic signaling contribution to central
chemoreception in vivo and in vitro. This was accomplished using the same methods as described in Aim
2. In vitro, loose patch recordings were made from CO2-sensitive neurons in the caudal NTS (cNTS) and
medullary raphe pallidus (RPa). These cells were assayed to see if they functionally express P2 receptors,
and if these receptors contribute to their chemosensitivity. Similarly, in vivo, cardiorespiratory responses
to hypercapnia in anesthetized rats were tested under control conditions and during P2 receptor blockade
in the cNTS and RPa. In addition, ATP injection into these regions was performed to test for functional
P2 receptor expression in vivo.
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Chapter 4 Astrocyte of the Retrotrapezoid Nucleus Sense H+ by Inhibition of a Kir4.1-Kir5.1-like
Current and May Contribute to Chemoreception by a Purinergic Mechanism

INTRODUCTION
A region of the caudal brain stem called the retrotrapezoid nucleus (RTN) contains a population of
neurons that are highly pH sensitive in vivo and in vitro, are glutamatergic, and project to respiratory
centers to influence breathing (Abbott, Stornetta et al. 2009, Mulkey, Stornetta et al. 2004). The
mechanism by which these RTN chemoreceptors sense pH involves inhibition of an unidentified voltageindependent K+ conductance (Mulkey, Stornetta et al. 2004). The absence of an identified molecular pH
sensor in RTN neurons has raised the possibility that multiple mechanisms contribute to chemoreception
(Filosa, Putnam 2003) and, despite the apparent intrinsic pH sensitivity of RTN neurons, it remains
possible that local paracrine mechanisms contribute to chemoreception by the RTN.

There is increasing evidence that adenosine 5′-triphosphate (ATP), released by astrocytes, is an important
mediator of chemoreception. Previous in vivo studies showed that hypercapnia evoked the discrete release
of ATP within the RTN (Gourine, Llaudet et al. 2005). Further, application of ATP into the RTN
stimulated respiratory output, whereas application of an ATP receptor antagonist (pyridoxal-phosphate-6azophenyl-2′,4′-disulfonate [PPADS]) to the RTN lowered CO2 respiratory responses (Gourine, Llaudet
et al. 2005). Recently, it was shown that RTN astrocytes respond to bath acidification with Ca2+dependent, exocytosis-mediated, ATP release (Gourine, Kasymov et al. 2010). In addition,
photostimulation of RTN astrocytes expressing channelrhodopsin-2 (ChR2) resulted in a robust increase
in breathing (Gourine, Kasymov et al. 2010), strongly suggesting that astrocytes contribute to respiratory
drive. This study also provided evidence suggesting that ATP release from astrocytes is a requisite signal
for neuronal pH sensitivity (Gourine, Kasymov et al. 2010). At the cellular level, we have shown that
purinergic signaling can activate pH-sensitive RTN neurons via P2Y receptors (Mulkey, Mistry et al.
2006). However, we also found that the pH sensitivity of RTN neurons in HCO3−-free HEPES-buffered
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media was retained when ATP receptors were blocked with PPADS (100 μM) (Mulkey, Mistry et al.
2006), indicating that ATP is not a requisite component of neuronal pH sensitivity. These results suggest
that RTN neurons are intrinsically pH sensitive but that CO2-evoked release of ATP can modulate the
activity of pH-sensitive neurons and contribute to the integrated output of the RTN (i.e., respiratory drive)
during hypercapnia.

The goals of this study were to 1) confirm that RTN astrocytes are pH sensitive, 2) identify mechanism(s)
by which these cells sense changes in pH, and 3) determine the extent to which they contribute to
chemoreception. To make these determinations, we used the brain slice preparation and a combination of
patch-clamp electrophysiology and immunohistochemistry to identity pH-sensitive glia and to determine
the mechanism by which they sense changes in pH. To explore the possibility that pH-sensitive RTN
astrocytes stimulate activity of pH-sensitive neurons by a purinergic mechanism, we determined the effect
of fluorocitrate-mediated astrocyte activation on pH-sensitive neurons. We found that pH-sensitive RTN
glia are protoplasmic astrocytes that sense H+, in part, by inhibition of a Kir4.1–Kir5.1-like current and
may contribute to respiratory drive by increasing activity of pH-sensitive RTN neurons by a purinergicdependent mechanism.

METHODS
Brain stem slices
Slices containing the RTN were prepared as previously described (Jiang, Xu et al. 2001, Matthias,
Kirchhoff et al. 2003). Briefly, neonatal rats (7–12 days postnatal) were decapitated under
ketamine/xylazine anesthesia and transverse brain stem slices (300 μm) were cut using a microslicer
(DSK 1500E; Dosaka, Kyoto, Japan) in ice-cold substituted Ringer solution containing (in mM): 260
sucrose, 3 KCl, 5 MgCl2, 1 CaCl2, 1.25 NaH2PO4, 26 NaHCO3, 10 glucose, and 1 kynurenic acid. Slices
were incubated for about 30 min at 37°C and subsequently at room temperature in normal Ringer solution
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(in mM): 130 NaCl, 3 KCl, 2 MgCl2, 2 CaCl2, 1.25 NaH2PO4, 26 NaHCO3, and 10 glucose. Both
substituted and normal Ringer solutions were bubbled with 95% O2-5% CO2.

Electrophysiology
Individual slices were transferred to a recording chamber mounted on a fixed-stage microscope (Zeiss
Axioskop FS) and perfused continuously (∼2 ml min−1) with a bath solution composed of (in mM): 140
NaCl, 3 KCl, 2 MgCl2, 2 CaCl2, 10 N-2-hydroxyethylpiperazin-N′-2-ethanesulfonic acid (HEPES), 10
glucose; pH was adjusted between 6.9 and 7.5 by addition of HCl or NaOH. To test pH sensitivity of
RTN astrocytes in bicarbonate-based buffer slices were perfused with normal Ringer solution bubbled
with 95% O2-5% CO2 (bath pH = 7.45). The pH of the bicarbonate-based bath solution was decreased to a
pH of about 6.8 by bubbling with 15% CO2 as previously described (Filosa, Putnam 2003).

All recordings were made with an Axopatch 200B patch-clamp amplifier, digitized with a Digidata
1322A A/D converter, and recorded using pCLAMP 10.0 software (Molecular Devices). Recordings were
obtained at room temperature with patch electrodes pulled from borosilicate glass capillaries (Warner
Instruments) on a two-stage puller (P89; Sutter Instrument) to a DC resistance of 4–7 MΩ when filled
with an internal solution containing the following (in mM): 120 KCH3SO3, 4 NaCl, 1 MgCl2, 0.5 CaCl2,
10 HEPES, 10 EGTA, 3 Mg-ATP, 0.2% biocytin, and 0.3 GTP-Tris (pH 7.2); electrode tips were coated
with Sylgard 184 (Dow Corning). Voltage-clamp recordings from glia were made at a holding potential of
−80 mV and in the presence of tetrodotoxin (TTX, 0.1 μM) to block neuronal activity. Holding current,
conductance, and current–voltage (I–V) relationships were determined using voltage steps between −40
and −150 mV. Neuronal firing rate histograms were generated by integrating action potential discharge in
10-s bins and plotted using Spike 5.0 software. It is important to recognize that in a whole cell recording
circuit, recording cells with a low membrane resistance (e.g., passive astrocytes) in series with a large
access resistance (Ra) can result in voltage-clamping error. In our experiments, we limited Ra to about 10
MΩ by preparing tissue from young animals; capacitance and Ra compensation (70%) were used to
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minimize voltage errors as previously described (Matthias, Kirchhoff et al. 2003). Recordings were
discarded if Ra varied >10% during an experiment. A liquid junction potential of 10 mV was corrected
off-line. Data were reported as means ± SE and were analyzed by the paired t-test or ANOVA and
Dunnett's multiple comparison test when appropriate (P < 0.05).

Immunohistochemistry
Recorded slices were fixed in 4% paraformaldehyde in 0.1 M sodium phosphate buffer (pH 7.4) for 2 h at
4°C and rinsed in phosphate-buffered saline (PBS). Slices were blocked and permeabilized in PBS
containing 5% normal goat serum and 0.4% Triton X-100 for 1 h at room temperature. Biocytin was
detected by incubation in Alexa 488–conjugated strepavidin (1:1,000; Invitrogen) for 1 h at room
temperature. After three PBS washes, the slices were incubated in primary antibodies overnight at 4°C,
washed, and then incubated in secondary antibodies for 1 h at room temperature. Slices were washed in
PBS and mounted in Vectashield. Images were collected on a Leica TCS SP2 confocal microscope
equipped with 488-, 543-, and 633-nm laser lines and tunable emission wavelength detection. For each
labeled slice, a biocytin-positive cell was identified and confocal z-stacks were collected sequentially for
the other two channels to detect glial antigens. A cell was scored as immunopositive if the
immunoreactivity for one or more glial markers was detected in the biocytin-positive cell body and
processes. To determine background fluorescence of the tissue and nonspecific binding of secondary
antibodies, we tested secondary antibodies without preincubation in primary antibody. These methods
have been optimized for 300-μm slices sequentially detecting biocytin and glial antigens.

Drugs
Tetrodotoxin was purchased from Alomone Labs (Bethlehem, Israel); all other chemicals were obtained
from Sigma (St. Louis, MO). Fluorocitrate was prepared as previously described (Holleran, Babbie et al.
2001). Briefly, the Ba2+ salt of fluorocitric acid was dissolved in 0.1 M HCl and the Ba2+ was precipitated
by the addition of Na2SO4 (0.1 M). This solution was centrifuged at 800 g for 10 min and the supernatant
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removed and diluted in HEPES-buffered medium to a final concentration of 100 μM (pH 7.3 by addition
of 1 N NaOH). To confirm that Ba2+ was adequately removed during the preparation of fluorocitrate, we
also prepared a solution of equal Ba2+ concentration minus fluorocitric acid and subjected it to the same
precipitation protocol described earlier.

RESULTS
This study consists of two series of experiments. First, I made whole cell recordings to identify pHsensitive RTN glia and to characterize the mechanism by which they sense pH. I initially identified glia
by their small size, hyperpolarized membrane potential, and inability to form action potentials during
depolarizing current injection; cellular identity was later confirmed using immunohistochemistry. In a
second series of experiments, I made loose-patch recordings from pH-sensitive RTN neurons to determine
the effects of fluorocitrate-mediated astrocyte activation on baseline activity and pH sensitivity of RTN
neurons and to test effects of P2-receptor antagonists on neuronal CO2 sensitivity.

Astrocyte chemoreceptors
Previous sharp electrode recordings showed that ≤44% of RTN glia respond to extracellular acidification
with membrane depolarization (Fukuda, Honda et al. 1978). In the whole cell configuration and HCO3−free HEPES-buffered solution we found that roughly 20% of RTN glia were pH sensitive; cells were
considered pH sensitive if they showed >10 mV/pH unit change in membrane potential, ≥40 pA change in
holding current, or 35% change in conductance when cycling bath pH between 7.5 and 6.9. Based on
these criteria, we found a bimodal distribution of pH-sensitive and -insensitive glial cells (Fig. 1F). In
current-clamp, pH-sensitive RTN glia have a resting membrane potential of −80 ± 1 mV (n = 8) and
respond to acidification from pH 7.5 to 6.9, with a depolarization of 8.8 ± 1.4 mV (n = 8) that occurs
within about 6 min (Fig. 1, A and B). We hypothesize that the slow kinetics of pH-sensitive astrocytes is
reflective of their modulatory role and likely helps maintain stable chemoreceptor output despite fast

18

Figure 1
Characteristics of pH-sensitive retrotrapezoid nucleus (RTN) glia in HEPES buffer. A: traces of
membrane potential and bath pH show that acidification from 7.3 to 6.9 causes a reversible
depolarization. B: summary of H+ effects on membrane potential of pH-sensitive astrocytes (n = 5, *P <
0.05). C: traces of holding current (top) and conductance (bottom) during changes in bath pH show that
alkalization increases and acidification decreases outward current and conductance. D and E: current
responses to voltage steps from −80 mV to between −40 and −150 mV (E) and corresponding current–
voltage (I–V) relationships under alkaline and acidic conditions (D). To isolate the pH-sensitive I–V (♣),
we subtract I–V relationships obtained at pH 6.9 (▴) from those recorded at pH 7.5 (■). F: percentage
change in conductance during acidification from pH 7.5 to 6.9 observed from all glial cells recorded in
the RTN. G: average I–V relationship (n = 5) of pH-sensitive current reverses near the equilibrium
potential for K+ (EK+, arrow).
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breath-by-breath oscillations in tissue pH (Millhorn, Eldridge et al. 1984). In contrast, pH-insensitive glia
have a resting membrane potential of −74 ± 3 mV (n = 12) that did not vary over the same pH range.
After recording, cells were filled with biocytin to characterize morphology and immunohistochemical
phenotype. We found that 18 of 20 (90%) pH-sensitive glia were immunoreactive for aldehyde
dehydrogenase 1L1 (Aldh1L1) (Fig. 2, A–C), an antigen that is expressed by protoplasmic astrocytes
(Cahoy, Emery et al. 2008). In addition, pH-sensitive glia typically extended numerous fine radial
projections near blood vessels (Fig. 2D) and to be dye-coupled (evidence of gap junctions) to other
astrocytes (Fig. 2, A–C). These results support recent evidence that GFAP-expressing cells near the
ventral surface are CO2 sensitive (Gourine, Kasymov et al. 2010) and indicate that pH-sensitive glia are
protoplasmic astrocytes.

To further characterize electrical properties of pH-sensitive astrocytes and establish their role as intrinsic
pH sensors, we made voltage-clamp recordings of whole cell currents in HEPES buffer at control pH 7.3
and during exposure to alkaline and acidic conditions. Note that these experiments were performed in
TTX (0.1 μM) to block neuronal activity. Under control conditions, pH-sensitive astrocytes display high
K+ conductance and exhibit fairly time- and voltage-independent responses to voltage steps. These
properties are consistent with those of passive astrocytes described in the hippocampus (Matthias,
Kirchhoff et al. 2003, Zhou, Schools et al. 2006) and brain stem (Grass, Pawlowski et al. 2004).
Astrocytes in the RTN respond to acidification from pH 7.5 to 6.9, with a decrease in holding current of
91.8 ± 10 pA (n = 23) and a decrease in conductance of 6.8 ± 0.8 nS (n = 23) (Fig. 1C). This corresponds
with a decrease in whole cell current of about 53% at +40 mV. By comparison, RTN astrocytes are more
pH sensitive than astrocytes in a nonrespiratory region like the hippocampus; passive hippocampal
astrocytes respond to acidification from 7.4 to 6.0 with a decrease in whole cell current at +20 mV of only
about 28% (Zhou, Xu et al. 2009). To confirm that the pH sensitivity of RTN astrocytes is determined by
intrinsic membrane properties, rather than intercellular current spread through gap junctions, we tested the
effects of carbenoxolone (a nonspecific gap junction blocker) on astrocyte pH sensitivity. Carbenoxolone
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Figure 2
pH-sensitive RTN glia are gap junction coupled protoplasmic astrocytes. A, left: a transverse slice
between bregma −11.6 to −11.2 mm that contains the RTN. Right: map showing relative locations of 18
pH-sensitive RTN astrocytes (green circles correspond to the cells shown in the bottom panels). B1 and
B2: biocytin filled pH-sensitive RTN glial cells (green, arrows) and dye-coupled cells (other green cells).
C1 and C2: aldehyde dehydrogenase 1L1-labeled (Aldh1L1, red) astrocytes. D1 and D2: merged images
of the same cells in B and C show double-labeling for biocytin (green) and Aldh1L1 (red); the pHsensitive astrocytes (arrows) and dye-coupled partners colocalize with Aldh1L1 labeling. E1 and E2:
merged images of the same cells in B and C show double-labeling for biocytin (green) and laminin (blood
vessels, blue). Note that pH-sensitive RTN astrocytes have cell bodies positioned near blood vessels (E1)
and extend processes to blood vessels (truncated arrows in E2). Each image is the average projection of a
confocal stack; around 30 images taken every 0.26 μm in the Z plane.
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(100 μM) increased the pH-sensitive current by roughly 18% (Data not shown), suggesting that RTN
astrocytes are intrinsically pH sensitive. Astrocytes are known to express high levels of the electrogenic
Na+/HCO3− cotransporter (NBC), which can generate an inward depolarizing current (i.e., HCO 3− efflux)
during bath acidification (Deitmer 1991, Munsch, Deitmer 1994). To determine whether activity of the
NBC contributes to the pH-sensitive current in RTN astrocytes, we characterized CO2/H+ sensitivity of
RTN astrocytes in normal Ringer solution (26 mM HCO3−, 5% CO2). In current-clamp, pH-sensitive RTN
astrocytes had a membrane potential of −82 ± 1.2 mV (n = 3), which is about 2 mV hyperpolarized to
resting potential of astrocytes in HCO3−-free HEPES buffer, and responded to hypercapnia (15% CO2,
pHo = 6.8) with a membrane depolarization of 9 ± 2.3 mV (Fig. 3, A and B). In voltage-clamp, exposure
to 15% CO2 decreased holding current from 139.8 ± 20 to 54.9 ± 8.9 pA (n = 8), which corresponded with
a change in holding current of 130 ± 17 pA/pH unit, whereas in HEPES buffer acidification from 7.3 to
6.9 changed in the holding current 62.7 ± 6 pA/pH unit (Fig. 3G). In addition, the CO2/H+-sensitive
current had a reversal potential of −105 mV (Fig. 3E), which is more negative than the reversal potential
of the pH-sensitive current in HCO3−-free HEPES buffer, suggesting that activity of one or more HCO3−
transporters contributes to pH sensitivity of RTN astrocytes. The most likely candidate is the electrogenic
NBC, which can generate a depolarizing inward current (i.e., HCO3− efflux) during bath acidification
(Chesler 2003, Deitmer 1991). Therefore we used diisothiocyanatostilbene-2,2′-disulfonic acid (DIDS, an
NBC blocker) to isolate the contribution of this transporter to pH sensitivity of RTN astrocytes. At control
pH = 7.4, exposure to DIDS (0.5 mM) decreased holding current by 41.6 ± 8 pA (n = 3) (Fig. 3C). In the
continued presence of DIDS, exposure to 15% CO2 decreased holding current by 45.2 ± 13 pA (n = 3)
(Fig. 3C), which corresponds with a change in holding current of 69.5 ± 20 pA/pH unit (Fig. 3G). The
CO2/H+-sensitive current in DIDS reversed at −94 mV (i.e., near the equilibrium potential for K + [EK+])
(Fig. 3, D and F), as expected for a current dominated by K+ conductance.

The DIDS-sensitive current exhibited a reversal potential of −104 mV, which is slightly hyperpolarized to
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Figure 3
Characteristics of pH-sensitive RTN glia in bicarbonate buffer. A: traces of membrane potential
shows that exposure to 15% CO2 causes a reversible membrane depolarization. B: summary of the effects
of 15% CO2 on membrane potential pH-sensitive astrocytes (n = 3). C: trace of holding current shows that
15% CO2 decreases outward current and conductance. Under control conditions (i.e., 5% CO2, pHo =
7.45), exposure to diisothiocyanatostilbene-2,2′-disulfonic acid (DIDS, 0.5 mM) also decreased holding
current close to 100 pA. In the continued presence of DIDS, a second exposure to 15% CO2 decreased
holding current also by about 100 pA. D and E: current responses to voltage steps from −80 mV to
between −40 and −150 mV during 5% and 15% CO2 exposure in bicarbonate buffer alone or in the
presence of DIDS (D) and corresponding I–V relationships of the average CO2/H+-sensitive current (i.e.,
difference current) (n = 3) in bicarbonate buffer alone (E) or bicarbonate buffer with DIDS (F). Note that
under control conditions the reversal potential of the CO2/H+-sensitive current is hyperpolarized to EK+
(arrow in E), but when activity of the electrogenic Na+/HCO3− cotransporter (NBC) is blocked with
DIDS, the CO2/H+-sensitive current reverses near EK+ (arrow in F). G: summary data comparing effects of
CO2/H+ on holding current (at a holding potential of −80 mV) in HEPES and bicarbonate-buffered media.
Activity of the NBC significantly increased acid-induced changes in holding current compared with
HCO3−-free HEPES solution or in the presence of DIDS (*P < 0.05).
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the predicted reversal potential for the NBC (ENBC). For example, the ENBC was calculated with the
following equation (Newman 1991): ENBC = RT/F(n − 1) ln [Na+]i[HCO3−]in/[Na+]o[HCO3−]on, where n is
the 2HCO3−:1Na+ stoichiometry and R (gas constant), T (temperature), and F (Faraday constant) have
their usual meanings. For a temperature of 22°C, [Na+]o = 157 mM, [Na+]i = 4 mM, [HCO3−]o = 26 mM,
and [HCO3−]i was estimated to be 22 mM using the Henderson–Hasselbalch equation as previously
described(Gross, Hawkins et al. 2001); we calculated ENBC to be −99 mV. It is not clear why the DIDSsensitive current reversed about 5 mV negative to ENBC, although DIDS has been shown to have
nonspecific effects on anion exchangers and Cl− channels in glia(Munsch, Deitmer 1994), which may
account for the discrepancy. To confirm that Cl− channels do not contribute to CO2 sensitivity of RTN
astrocytes, we tested CO2 sensitivity in low chloride (50 mM) buffer.

The low Cl− solution was made isoosmotic by replacing 80 mM NaCl with an equal amount of Nagluconate. We found the CO2/H+-sensitive current was not affected by chloride reduction. For example,
there was no difference between the CO2/H+-induced change in holding current under control conditions
(92.3 ± 38 pA; n = 3) and in low Cl− buffer (91.3 ± 37 pA; n = 3) (not shown). Likewise, amplitude and
reversal potential of the CO2/H+-sensitive current were similar in control and low Cl− conditions (data not
shown).

In the absence of NBC activity (HCO3−-free HEPES buffer or Ringer solution with DIDS), the CO2/H+sensitive current expressed by RTN astrocytes reversed near the equilibrium potential for K + (EK+ = −97
mV), suggesting that one or more pH-sensitive K+ channels contribute to the pH sensitivity of RTN
astrocytes. Astrocytes have been shown to express several types of pH-sensitive K+ channels, including
background TASK channels and heteromeric Kir4.1–Kir5.1 channels. In particular, heteromeric Kir4.1–
Kir5.1 channels are exquisitely sensitive to pH in the physiological range (Casamassima, D'Adamo et al.
2003, Xu, Yang et al. 2000), are preferentially expressed by astrocytes (Hibino, Fujita et al. 2004, Tang,
Taniguchi et al. 2009), and in situ hybridization shows detectable levels of both Kir4.1 and Kir5.1 mRNA
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in the RTN (Wu, Xu et al. 2004). Therefore we consider heteromeric Kir4.1–Kir5.1 channels the most
likely molecular pH sensor in RTN astrocytes.

Heteromeric Kir4.1–Kir5.1 channels confer pH sensitivity to RTN astrocytes
The possible contribution of Kir channels can easily be distinguished from background K + channels based
on Ba2+ sensitivity (Olsen, Sontheimer 2008); most Kir channels, but not background K+ channels, are
fully inhibited by micromolar concentrations of Ba2+ (for review of background and Kir channel
pharmacology see (Kubo, Adelman et al. 2005, Goldstein, Bayliss et al. 2005, Patel, Honore 2001).
Therefore to determine whether heteromeric Kir4.1–Kir5.1 channels contribute to pH sensitivity in RTN
astrocytes, we first determine effects of Kir channel inhibition by Ba2+ (100 μM) on membrane potential
and the pH-sensitive current. In current-clamp, Ba2+ depolarized the membrane potential by 16.7 ± 3.0
mV (n = 4) (Fig. 4A). In voltage-clamp (at −80 mV, TTX), Ba2+ decreased outward current by 86.5 ± 5
pA (n = 4) (Fig. 4B) and blocked the pH-sensitive current by 96.5 ± 3.5% (n = 4) (Fig. 4, B, D, and F).
Note that if a more Ba2+-sensitive background channel like TWIK (Ba2+ half-maximal inhibitory
concentration [IC50] = 100 μM; (Patel, Honore 2001)) or TASK-1 (Ba2+ IC50 = 350 μM; (Patel, Honore
2001)) contributed to the pH-sensitive current in RTN astrocytes, we would expect that only a portion (at
best ∼50%) of the pH-sensitive current would be blocked by 100 mM Ba2+. However, we show that this
concentration of Ba2+ virtually eliminated the pH-sensitive current, suggesting that background K+
channels do not confer pH sensitivity to RTN astrocytes. Inhibition of other voltage-gated K+ channels
with tetraethylammonium (TEA, 10 mM) or 4-aminopyridine (4-AP, 50 μM) had no effect on the pHsensitive current in RTN astrocytes (Supplemental Fig. S1A). These results indicate that one or more Kir
channels contribute to the pH-sensitive current in RTN astrocytes.

To differentiate the contribution of Kir4.1–Kir5.1 channels from other Kir channels, we inhibited Kir4.1containing channels (i.e., homomeric and heteromeric channels) with desipramine (100 μM). At this
concentration, desipramine inhibits channels containing Kir4.1 subunits, with minimal effects on other
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Figure 4
pH sensitivity of RTN glia involves heteromeric Kir4.1 channels. A1: membrane potential trace shows
that inhibition of Kir channels mimics the effects of H+; Ba2+ (100 μM) and desipramine (des, 100 μM)
depolarize membrane potential by about 18 and 9 mV, respectively. A2: average depolarization of RTN
pH-sensitive astrocyte when exposed to either H+ (acidification from 7.3 to 6.9, n = 5), 100 μM Ba2+ (n =
4), or 100 μM desipramine (n = 5). B: trace of holding current shows that H+ decreases outward current.
At pH 7.3, Ba2+ decreases holding current and blocks effects of pH on holding current. C: trace of holding
current from a pH-sensitive astrocyte shows desipramine decreases holding current and blocks effects of
pH on holding current. D: average (n = 4) I–V relationship of the pH-sensitive current under control
conditions and in the presence of 100 μM Ba2+ shows negligible pH-sensitive current in Ba2+. E: average
(n = 4) I–V relationship of the pH-sensitive current under control conditions and in the presence of
desipramine shows negligible pH-sensitive current in desipramine. F: average pH-sensitive current
amplitude (at −80 mV) recorded from RTN astrocytes during acidification from pH 7.5 to 6.9, exposure
to Ba2+ (n = 3), or desipramine (n = 4) (*P < 0.05).
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pH-sensitive Kir channels (Su, Ohno et al. 2007, Tang, Taniguchi et al. 2009). Our results indicate that
desipramine mimics effects of acidification; in current-clamp exposure to desipramine depolarized
membrane potential by 8.4 ± 3.0 mV (n = 4) (Fig. 4A) and in voltage-clamp it decreased holding current
by 35.0 ± 13 pA (n = 4) (Fig. 4C) and the pH-sensitive current by 72.7 ± 21.3% (n = 4) (Fig. 4, C, E, and
F). It should be noted that desipramine is also a tricyclic antidepressant and may have nonspecific effects
on neuronal activity. However, RTN astrocytes are not responsive to norepinephrine or serotonin (DK
Mulkey, unpublished observations), suggesting the effects of desipramine on these cells is mediated by
inhibition of Kir4.1-containing channels. These results suggest that heteromeric Kir4.1–Kir5.1 channels
confer pH sensitivity to RTN astrocytes.

RTN astrocytes activate pH-sensitive neurons by a purinergic mechanism
Recent evidence suggests that a subset of RTN astrocytes contribute to the mechanism of chemoreception
by sensing CO2/H+ and releasing ATP to activate pH-sensitive neurons and increase respiratory drive
(Gourine, Kasymov et al. 2010). These results are supported by our evidence that roughly 20% of RTN
astrocytes are intrinsically pH sensitive. To test the possibility that pH-sensitive astrocytes modulate
activity of pH-sensitive neurons, we paralleled previous in vivo experiments by using fluorocitrate to
selectively depolarize astrocytes (Erlichman, Li et al. 1998, Holleran, Babbie et al. 2001) while recording
activity of pH-sensitive neurons. Fluorocitrate is a metabolic toxin that is selectively taken up by
astrocytes, where it can initiate membrane depolarization (Erlichman, Leiter 2010), presumably by energy
depletion and loss of cytoplasmic K+. At subtoxic doses, fluorocitrate has been shown to reversibly
depolarize RTN glia and increase ventilatory sensitivity to CO2 (Erlichman, Li et al. 1998, Holleran,
Babbie et al. 2001), by yet unknown mechanisms. We confirmed that fluorocitrate (50 μM) can reversibly
depolarize pH-sensitive astrocytes (data not shown). We also confirmed the effects of fluorocitrate are not
due to residual Ba2+ by determining that Ba2+ precipitation control solution, prepared in a manner similar
to fluorocitrate, had no effect on neuronal or glial membrane potential. We found that fluorocitrate
evoked a large and reversible neuronal activation (Fig. 5, A and B). Importantly, a second exposure to
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Figure 5
RTN astrocytes increase baseline activity and pH sensitivity of RTN chemoreceptors by a P2receptor–dependent mechanism. A: traces of pH and firing rate (Hz) from a pH-sensitive neuron shows
a characteristic response to H+: increasing pH to 7.5 inhibited activity, whereas acidification to pH 6.9
increased firing rate >2 Hz. At a control pH of 7.3, exposure to fluorocitrate (fluoro, 50 μM) evoked a
large and reversible increase in neuronal activity. A second exposure to fluorocitrate, this time in the
presence of a P2-receptor antagonist pyridoxal-phosphate-6-azophenyl-2′,4′-disulfonate (PPADS), 100
μM, blocked the effects of fluorocitrate. Fluorocitrate responsiveness returned in wash. B: traces of pH
and firing rate from a pH-sensitive RTN neuron exposed to acidic and alkaline conditions in the presence
and absence of fluorocitrate (fluoro, 50 μM) or PPADS (100 μM). Fluorocitrate alone stimulated neuronal
activity. In the continued presence of fluorocitrate, acidification further increased firing rate by about 1
Hz, whereas alkalization decreased activity. Note that the effects of pH but not fluorocitrate were retained
in the presence of PPADS. Bar graphs summarize the effects of fluorocitrate in the presence of PPADS
(top, n = 5) and in acidic and alkaline conditions (bottom, n = 3) (*P < 0.05).

32

33

fluorocitrate, this time in the presence of an ATP receptor antagonist (PPADS, 100 μM), had no effect on
neuronal activity (Fig. 5A). In addition, fluorocitrate also increased neuronal pH sensitivity; in the
continued presence of fluorocitrate, responsiveness to acidification increased by 0.7 ± 0.2 Hz (n = 3),
compared with acid alone (Fig. 5B). These results also confirm previous results that P2 receptors are not
required for pH sensitivity of RTN neurons in slices incubated in HEPES buffer (Mulkey, Mistry et al.
2006); pH sensitivity of RTN neurons was wholly retained in the presence of PPADS (Fig. 5B). It has
been suggested that CO2 and not H+ per se is the stimulus required for ATP release from RTN astrocytes
(Spyer 2009). Therefore we tested the effect of PPADS and another P2-receptor antagonist (suramin, 100
μM) on CO2/H+ sensitivity in bicarbonate-buffered medium. As shown in Fig. 6, exposure to 15% CO2
alone increased neuronal activity 2.2 ± 0.1 Hz (n = 12). After washing to 5% CO2 exposure to PPADS
(100 μM) significantly decreased baseline activity from 0.13 ± 0.05 to 0.02 ± 0.01 Hz (n = 8). Likewise,
suramin (100 μM) decreased baseline activity 0.50 ± 0.1 Hz to 0.3 ± 0.1 Hz (n = 4). These results suggest
that in bicarbonate buffer (pH 7.3) RTN chemoreceptors receive tonic excitatory purinergic input. Prior to
testing CO2/H+ sensitivity in PPADS or suramin, a depolarizing current (∼1 nA) was delivered to the
neuron to approximate the control level of activity. In the continued presence of PPADS (with baseline
activity adjusted by DC current injection to near control levels), a second exposure to 15% CO 2 increased
neuronal activity by 1.6 ± 0.1 Hz (n = 8); this response was significantly less than the CO2 response under
control conditions (initial response or in wash) (Fig. 6A). In the presence of suramin (with baseline
activity adjusted to near control levels), a second exposure to 15% CO2 increased neuronal activity by 1.4
± 0.1 Hz; this response was significantly less than the CO2 response under control conditions (Fig. 6B).
These results indicate that P2-receptor antagonists PPADS and suramin decreased CO2/H+ sensitivity. To
the extent that fluorocitrate selectively affects astrocytes (Erlichman, Leiter 2010), these results suggest
that astrocytes can release ATP and activate pH-sensitive neurons, presumably by a P2Y-dependent
mechanism (Mulkey, Mistry et al. 2006), to increase chemoreceptor output. These results also lend
support to the hypothesis that pH-sensitive astrocytes contribute to chemoreception by increasing activity
of pH-sensitive neurons.
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Figure 6
In bicarbonate-buffered solution astrocytes contribute to chemosensitivity by a purinergic
mechanism. A: trace of firing rate shows the response of an RTN neuron to increases in CO 2 from 5 to
15% in bicarbonate buffer alone or in the presence of PPADS. An initial exposure to 15% CO 2 increased
the firing rate about 2.8 Hz. After returning to 5% CO2, exposure to PPADS (100 μM) decreased baseline
firing rate, suggesting that in bicarbonate buffer RTN chemoreceptors receive tonic excitatory purinergic
input. A depolarizing current (∼1 nA) was delivered to the neuron to increase firing rate to near control
levels. In the continued presence of PPADS (with baseline activity adjusted by DC current injection to
near control levels), a second exposure to 15% CO2 increased the firing rate about 1.5 Hz. After washing,
PPADS CO2 sensitivity returned to initial levels. Bar graph on the right summarizes the firing rate
response of RTN neurons (n = 9) to 15% CO2 in control and PPADS (*P < 0.05). B: firing rate trace
shows the response of a RTN chemoreceptor to 15% CO2 in bicarbonate-buffered solution alone and in
the presence of suramin (100 μM). An initial exposure to 15% CO2 increased the firing rate about 2.7 Hz.
As was observed with PPADS, exposure to suramin (100 μM) in 5% CO2 decreased baseline firing rate.
A depolarizing current (∼1 nA) was delivered to the neuron to increase firing rate to near control levels.
In the continued presence of suramin (with baseline activity adjusted by DC current injection to near
control levels), a second exposure to 15% CO2 increased firing rate about 1.7 Hz. After washing, suramin
CO2 sensitivity returned to initial levels. The asterisk designates a 5-min break. Bar graph on the right
summarizes the firing rate response of RTN neurons (n = 5) to 15% CO2 in control and suramin (*P <
0.05).
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DISCUSSION
Neuron–glia communication has emerged in recent years as a fundamental process in the brain that can be
an important determinant of neuronal activity. However, by most accounts the activity of astrocytes is
thought to be under the strict control of neuronal input (Fellin, Pascual et al. 2006). Here we show that
RTN astrocytes sense H+ in part by inhibition of heteromeric Kir4.1–Kir5.1 channels and stimulate
activity of RTN chemoreceptors by a P2-receptor–dependent mechanism. Our evidence also indicates that
purinergic input is not required for RTN chemoreceptor function. These results identify the most likely
mechanism by which RTN astrocytes sense pH and build on recent evidence that astrocytes contribute to
respiratory drive by a purinergic mechanism (Gourine, Kasymov et al. 2010).

Molecular mechanism underlying pH sensing by RTN astrocytes
Fukuda and colleagues showed >30 years ago that the RTN contains a population of pH-sensitive
nonspiking cells (Fukuda, Honda et al. 1978) and more recent evidence shows these pH sensors express
the NBC (Ritucci, Erlichman et al. 2005), thus narrowing the scope of candidates to either astrocytes or
oligodendrocytes. Our data indicate that pH-sensitive RTN glia are protoplasmic astrocytes; specifically,
these cells have a hyperpolarized membrane potential; high K+ conductance; exhibit an electrically
passive profile; and express Aldh1L1, a marker of protoplasmic astrocytes (Cahoy, Emery et al. 2008).

Several pH-sensitive channels have been proposed to contribute to the mechanism of chemoreception,
including Ca+2-activated K+ channels (KCa) (Wellner-Kienitz, Shams et al. 1998), voltage-sensitive K+
channels (e.g., transient and delayed rectifying K+ channels)(Putnam, Filosa et al. 2004, Filosa, Putnam
2003), background TASK channels (Bayliss, Talley et al. 2001, Mulkey, Stornetta et al. 2004), and Kir
channels(Schultz, Czachurski et al. 2003, Zhu, Liu et al. 2000, Xu, Cui et al. 2000). All of these channels
are expressed in various types of glial cells and conceivably contribute to the pH sensitivity of RTN
astrocytes. Our results show that the pH-sensitive current in RTN astrocytes can be blocked with 100 μM
Ba2+, which will fully block most Kir channels, with only modest effects on background K + channels
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(e.g., TASK channels) (Goldstein, Bayliss et al. 2005, Kubo, Adelman et al. 2005, Patel, Honore 2001).
In addition, the pH-sensitive current in RTN astrocytes was not blocked by TEA (10 mM) or 4-AP (50
μM), which can inhibit other voltage- and Ca2+-dependent K+ channels, thus narrowing the scope of
candidate molecular sensors to one or more Kir channels.

The Kir family of channels consists of 16 different channel subunits grouped into seven subfamilies
(Kir1.x–Kir7.x) based on sequence homology (Olsen, Sontheimer 2008). All Kir channels are composed
of four α-subunits assembled as homomeric or heteromeric channels that show varying degrees of
rectification, single-channel conductance, and pharmacology. A common feature of most Kir channels is
high sensitivity to low micromolar concentrations of Ba2+ (Kubo, Adelman et al. 2005, Mulkey, Stornetta
et al. 2004), a property that is frequently used to differentiate contributions of Kir channels from other K+
channels, including background K+ channels (Mulkey, Stornetta et al. 2004). Only certain Kir channels
are pH sensitive, e.g., Kir1.1 (pK = 6.7) (Xu, Yang et al. 2000), Kir2.3 (pK = 6.8) (Putnam, Filosa et al.
2004), homomeric Kir4.1 (pK = 6.1) (Pessia, Imbrici et al. 2001), and the heterodimeric Kir4.1–Kir5.1
channels (pK = 7.4) (Casamassima, D'Adamo et al. 2003, Xu, Yang et al. 2000). Note that Kir5.1 subunits
do not form functional homomeric channels, but preferentially heteromerize with Kir4.1 subunits in
astrocytes (Casamassima, D'Adamo et al. 2003, Pessia, Tucker et al. 1996). Of all pH-sensitive Kir
channels, only heteromeric Kir4.1–Kir5.1 channels are exquisitely sensitive to physiologically relevant
pH changes. Further, in situ hybridization found that the RTN expresses high levels of Kir4.1 and Kir5.1
mRNA (Wu, Xu et al. 2004). Here, we show that RTN astrocytes respond to physiologically relevant pH
changes. The pH-sensitive current expressed by these cells appears relatively voltage independent
between −150 and −30 mV and was almost completely blocked by micromolar concentrations of Ba2+ and
desipramine (a blocker of Kir4.1-containing channels; (Su, Ohno et al. 2007, Tang, Taniguchi et al.
2009)). This combination of features (i.e., inhibition by physiologically relevant changes in pH and
micromolar concentrations of Ba2+ and desipramine) is most consistent with heteromeric Kir4.1–Kir5.1
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channels. Therefore we consider heteromeric Kir4.1–Kir5.1 channels to be excellent candidate pH sensors
of RTN astrocytes.

Our results also indicate that the NBC contributes to the pH-sensitive current in RTN astrocytes. It is well
established in various types of astrocytes that activity of the NBC generates a hyperpolarizing outward
current (i.e., net HCO3− influx) at membrane potentials depolarized to ENBC (Chesler 2003). In our
experimental conditions we calculated the ENBC to be about −99 mV. As expected, at a holding potential
of −80 mV in bicarbonate-buffered solution we observed a DIDS-sensitive outward current. This outward
current will likely increase during depolarization and so potentially blunt H+-mediated inhibition of
Kir4.1–Kir5.1 and the corresponding membrane potential. However, the NBC is also modulated by
changes in extracellular pH; bath acidification can reverse Na +-HCO3− transport to produce an inward
depolarizing current (i.e., net HCO3− efflux) (Chesler 2003, Deitmer 1991). In voltage-clamp (at a holding
potential of −80 mV), we show that inward current produced by the NBC increased amplitude of the
CO2/H+-sensitive current and caused a negative shift in its reversal potential. When activity of the NBC
was blocked with DIDS, we observed a CO2/H+-sensitive current that was similar in amplitude to that of
the pH-sensitive current in HCO3−-free HEPES solution and reversed near EK+. A contribution of the
NBC to central chemoreception has yet to be established and considering that H+-induced depolarization
and extracellular acidification have offsetting effects on directionality of Na+/HCO3− transport by the
NBC, further experiments are required to define potential roles of this transporter in RTN
chemoreception.

Possible role of astrocytes in central chemoreception
There are two mechanisms by which astrocytes are thought to influence chemoreception. First, a wellknown function of astrocytes is to help regulate extracellular K+ by taking up extracellular K+ ions during
increased neuronal activity (Olsen, Sontheimer 2008). This process effectively buffers changes in
extracellular K+; however, it can also depolarize membrane potential and increase Na+/HCO3− cotransport
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into glia (Chesler 2003), which would enhance the CO2-induced fall in extracellular pH and potentiate
activation of chemoreceptors. This possibility is supported by a series of in vivo experiments in which
fluorocitrate microinjected into the RTN caused extracellular acidification followed by increased
respiratory frequency and ventilatory sensitivity to CO2 (Erlichman, Leiter 2010, Holleran, Babbie et al.
2001). Note that fluorocitrate is a toxin that inhibits metabolic activity; at low concentrations it has been
shown to be selectively taken up by astrocytes but not neurons, where it initiates membrane
depolarization (Erlichman, Leiter 2010), presumably by loss of cytoplasmic K+. However, it is also
possible that the fluorocitrate-mediated effects described in these experiments resulted from the release of
excitatory gliotransmitters acting on pH-sensitive neurons. Our data support this latter possibility. For
example, we found that exposure to fluorocitrate activated pH-sensitive neurons under conditions in
which the NBC is minimally active (i.e., in HEPES buffer). In addition, we were able to block effects of
fluorocitrate with a P2-receptor antagonist. Therefore the most likely mechanism by which astrocytes
contribute to chemoreception involves release of ATP and activation of pH-sensitive neurons. Our data
also indicate that fluorocitrate caused an upward parallel shift in the pH sensitivity of RTN neurons,
suggesting that fluorocitrate-mediated ATP release from RTN astrocytes contributes to chemoreception
by increasing excitability of RTN neurons. These results are consistent with evidence in other brain
regions that astrocytes serve as a source of excitatory purinergic drive able to rapidly modulate neural
activity (Gordon, Iremonger et al. 2009). However, it should be noted that these experiments are limited
by a dearth of pharmacological tools available to selectively manipulate astrocytes and the possibility that
fluorocitrate may have nonspecific effects on other cell types, including neurons. Therefore additional
experiments that use genetic approaches to selectively manipulate astrocytes are required to definitively
establish a role of pH-sensitive astrocytes in chemoreception. It is important to note that our results are
entirely consistent with a recent study that used the adenoviral system to target expression of ChR2 to
RTN astrocytes (Gourine, Kasymov et al. 2010). This study showed that photostimulation of RTN
astrocytes increased activity of RTN neurons and stimulated breathing by a purinergic-dependent
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mechanism. These results are similar to the observed effects of fluorocitrate, thus adding to our
confidence that fluorocitrate effects are mediated by astrocytes.

Based on the results described earlier, it is reasonable to expect P2-receptor antagonists to decrease pH
sensitivity of RTN neurons. However, previous experiments performed in HEPES-buffered media
(Mulkey, Mistry et al. 2006) indicate that PPADS had no effect on pH sensitivity of RTN neurons. A
possible explanation for this apparent discrepancy is that CO2, not H+, is the effector responsible for
hypercapnic-induced ATP release (Spyer, Gourine 2009). Therefore in a parallel series of experiments,
we tested the effects of two P2-receptor antagonists (PPADS and suramin) on CO2/H+ sensitivity of RTN
neurons in bicarbonate-buffered media. Interestingly, we found that under these conditions both P2receptor antagonists blunted neuronal CO2/H+ sensitivity. These results are consistent with the possibility
that CO2 is the required stimulus for ATP release in the RTN.

In summary, we demonstrate that pH-sensitive RTN glia are protoplasmic astrocytes that sense H+ by
inhibition of heteromeric Kir4.1–Kir5.1-like conductance and contribute to respiratory drive by increasing
activity of pH-sensitive neurons by a purinergic-dependent mechanism. Our results also suggest that the
NBC may contribute to the pH-sensitive current in RTN astrocytes. Thus we conclude that RTN
astrocytes contribute to the mechanism of chemoreception and influence integrated output of the RTN.
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Chapter 5 Regulation of Ventral Surface CO2/H+-sensitive neurons by purinergic signaling

INTRODUCTION
Carbon dioxide provides the primary stimulus to breathe. Central respiratory chemoreceptors sense
changes in tissue CO2, H+ and/or HCO3− to regulate the rate and depth of breathing (for review see
(Huckstepp, Dale 2011)). It is now well established that the retrotrapezoid nucleus (RTN) is an important
site of chemoreception. Specifically, the RTN contains a subset of neurons that is highly CO2/H+ sensitive
in vivo and in vitro, is glutamatergic and projects to respiratory centres to directly influence breathing
(Mulkey, Stornetta et al. 2004, Takakura, Moreira et al. 2008, Ritucci, Erlichman et al. 2005, Nattie, Fung
et al. 1993, Abbott, Stornetta et al. 2009, Weston, Stornetta et al. 2004). The mechanism by which RTN
neurons sense pH involves inhibition of an unidentified voltage-independent K+ conductance (Mulkey,
Stornetta et al. 2004, Mulkey, Talley et al. 2007). Evidence also indicates that purinergic signalling
contributes to the ventilatory response to CO2 (Gourine, Llaudet et al. 2005, Gourine, Atkinson et al.
2003, Thomas, Spyer 2000, Thomas, Ralevic et al. 1999). At the level of the RTN, hypercapnia has been
shown to evoke the discrete release of ATP near the ventral medullary surface (Huckstepp, id Bihi et al.
2010, Gourine, Kasymov et al. 2010, Gourine, Llaudet et al. 2005), and ATP has been shown to
contribute to respiratory drive by increasing activity of CO2/H+-sensitive RTN neurons (Mulkey, Mistry
et al. 2006, Gourine, Kasymov et al. 2010, Wenker, Kreneisz et al. 2010).

There is increasing evidence that astrocytes are the source of purinergic drive to RTN chemoreceptors
(Huckstepp, id Bihi et al. 2010, Wenker, Kreneisz et al. 2010, Gourine, Kasymov et al. 2010); however,
the extent to which ATP contributes to RTN chemoreception is questionable and the mechanisms
underlying purinergic modulation of RTN chemoreceptors are not clear (Mulkey, Wenker 2011). For
example, a recent study reported that H+ sensitivity of RTN neurons could be blocked with a P2 receptor
antagonist (Gourine, Kasymov et al. 2010), suggesting that RTN chemoreception is entirely dependent on
purinergic signalling. The same study also suggested that the purinergic drive to RTN neurons is
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dependent on extracellular Ca2+; it showed that acidification triggered a Ca2+ wave that propagated
between ventral surface astrocytes, possibly by activating Ca2+-permeable channels (e.g. P2X1 or P2X3),
to potentiate additional ATP release and subsequently activate Phox2b-expressing RTN neurons in vitro
and increased respiratory activity in vivo. Conversely, we have shown in vitro that RTN neurons are
highly pH sensitive in the presence of P2 receptor blockers, and that purinergic signalling contributes to
only a portion of neuronal CO2/H+ sensitivity (Mulkey, Mistry et al. 2006, Wenker, Kreneisz et al. 2010).
Still further evidence obtained using the brainstem–spinal cord preparation reported that purinergic
signalling does not contribute to CO2 responsiveness of neurons in the parafacial respiratory group
(pFRG)/RTN of newborn rats (Onimaru, Ikeda et al. 2012). In addition, the mechanism underlying CO2evoked ATP release in the RTN appears to be mediated by direct gating of gap junction hemichannels in a
Ca2+-independent manner (Huckstepp, id Bihi et al. 2010).

The objectives of this study are to establish the extent to which purinergic signalling contributes to RTN
chemoreception both in vivo and in vitro, and to gain insight into the mechanisms underlying CO2-evoked
ATP release and downstream activation of RTN neurons. To make these determinations, we recorded
phrenic nerve activity in vivo or the firing rate response of CO2/H+-sensitive RTN neurons in the brain
slice preparation during exposure to hypercapnia alone and in the presence of P2 receptor blockers. In
addition, we used a pharmacological approach to manipulate potential mechanisms of ATP release and
activity of downstream P2 receptors. We find that purinergic signalling is an important component of
RTN chemoreception; application of P2 receptor antagonists into the RTN reduced the ventilatory
response to CO2 by ∼30% in vivo, and blunted the firing rate response of RTN neurons to both 10% and
15% CO2 also by 30%. This purinergic drive to breathe was independent of temperature, stimulus
strength and changes in the extracellular Ca2+ gradient, but could be blocked with gap junction
hemichannel antagonists. These results are most consistent with a recent study by Huckstepp and
colleagues (Huckstepp, id Bihi et al. 2010), and suggest that astrocytes but not neurons mediate CO2evoked ATP release by a mechanism involving gap junction hemichannels.
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METHODS
In vivo preparation
Animal use was in accordance with guidelines approved by the University of São Paulo Animal Care and
Use Committee and conforms to the principles of UK regulations, as described in (Drummond 2009). All
efforts were made to minimize the number of animals used and their suffering. All in vivo experiments
were performed in male Wistar rats weighing 250–280 g; a total of 38 rats were used for these in vivo
experiments. The surgical procedures and experimental protocols were similar to those previously
described (Takakura, Moreira et al. 2011, Takakura, Moreira 2011). Briefly, general anaesthesia was
induced with 5% halothane in 100% O2. A tracheostomy was made and the halothane concentration was
reduced to 1.4–1.5% until the end of surgery. The femoral artery was cannulated (polyethylene tubing, 0.6
mm o.d., 0.3 mm i.d., Scientific Commodities, Lake Havasu City, AZ, USA) for measurement of arterial
pressure (AP). The femoral vein was cannulated for administration of fluids and drugs. The occipital plate
was removed, and a micropipette was placed in the medulla oblongata via a dorsal transcerebellar
approach for microinjection of drugs. A skin incision was made over the lower jaw for placement of a
bipolar stimulating electrode, next to the mandibular branch of the facial nerve, as previously described
(Moreira, Takakura et al. 2006, Takakura, Moreira et al. 2011). The phrenic nerve was accessed by a
dorsolateral approach after retraction of the right shoulder blade. To prevent any influence of artificial
ventilation on phrenic nerve activity (PNA), the vagus nerve was cut bilaterally. Additionally, a complete
baro- and peripheral chemoreceptor deafferentation was performed by sectioning the vagosympathetic
trunks, the superior laryngeal nerves and the glossopharyngeal nerves (proximal to the junction with the
carotid sinus nerves). Upon completion of the surgical procedures, halothane was replaced with urethane
(1.2 g kg−1) administered slowly i.v. All rats were ventilated with 100% O2 throughout the experiment.
Rectal temperature was maintained at 37°C. End-tidal CO2 was monitored throughout each experiment
with a capnometer (CWE, Inc., Ardmore, PA, USA) that was calibrated twice per experiment with a
calibrated CO2–N2 mix. This instrument provided a reading of <0.1% CO2 during inspiration in animals
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breathing 100% O2, and an asymptotic, nearly horizontal reading during expiration. The adequacy of
anaesthesia was monitored during a 20 min stabilization period by testing for the absence of withdrawal
responses, pressor responses and changes in PNA to a firm toe pinch. After these criteria were satisfied,
the muscle relaxant pancuronium was administered at an initial dose of 1 mg kg−1 i.v. and the adequacy of
the anaesthesia was thereafter gauged solely by the lack of increase in AP and PNA rate or amplitude to a
firm toe pinch. Approximately hourly supplements of one-third of the initial dose of urethane were
needed to satisfy these criteria throughout the recording period (2 h).

In vivo recordings of physiological variables
As previously described (Mulkey, Stornetta et al. 2004, Moreira, Takakura et al. 2006, Takakura, Moreira
et al. 2011), mean arterial pressure (MAP), phrenic nerve activity (PNA) and end-expiratory CO2 (etCO2)
were digitized with a micro1401 (Cambridge Electronic Design), stored on a computer and processed offline with version 6 of Spike 2 software (Cambridge Electronic Design). Integrated phrenic nerve activity
(iPNA) was obtained after rectification and smoothing (τ = 0.015 s) of the original signal, which was
acquired with a 30–300 Hz bandpass filter. PNA amplitude (PNA amp) and PNA frequency (PNA freq)
were expressed for each rat on a scale from 0 (value during apnoea) to 100 (value while breathing 10%
CO2).
Hypercapnia was produced by addition of pure CO2 to the 100% O2 supplied by artificial ventilation to
increase the maximum end-expiratory CO2 to 9.5–10%. End-expiratory CO2 was maintained for 5 min,
and CO2 was removed. Each rat was submitted to three sessions of hypercapnia: one session 10 min after
bilateral saline injections into the RTN, and two additional sessions, 10 and 60 min after bilateral
injections of saline, PPDAS or MRS2179 into the RTN.

Histology
At the end of each in vivo experiment, rats were deeply anaesthetized with halothane and perfused
through the heart with PBS (pH 7.4) followed by paraformaldehyde (4% in 0.1 m phosphate buffer, pH
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7.4). The brains were removed and stored in fixative for 24 h at 4°C. The medulla was cut in 40-µm-thick
coronal sections with a vibrating microtome (Vibratome 1000S Plus, USA). Sections were stored at
−20°C in a cryoprotectant solution. The injection sites were confirmed with an Axioskop 2 microscope
(Zeiss, Oberkochen, Germany). Sections from different brains were aligned with respect to a reference
section, which was the most caudal section containing an identifiable cluster of facial motor neurons. To
this reference section was assigned a value of 11.6 mm caudal to bregma (bregma −11.6 mm, (Paxinos,
Watson 1982)). Levels rostral or caudal to this reference section were determined by adding or
subtracting the number of intervening sections × 40 μm.

Brain slice preparation
All procedures were performed in accordance with National Institutes of Health and University of
Connecticut Animal Care and Use Guidelines and conformed to the principles of UK regulations, as
described in (Drummond 2009). A total of 64 rat pups were used for these in vitro experiments. Slices
containing the RTN were prepared as previously described (Mulkey, Mistry et al. 2006, Wenker, Kreneisz
et al. 2010). Briefly, neonatal rats (7–12 days postnatal) were decapitated under ketamine–xylazine
anaesthesia and transverse brainstem slices (300 μm) were cut using a microslicer (DSK 1500E; Dosaka,
Kyoto, Japan) in ice-cold substituted Ringer solution containing (in mm): 260 sucrose, 3 KCl, 5 MgCl 2, 1
CaCl2, 1.25 NaH2PO4, 26 NaHCO3, 10 glucose and 1 kynurenic acid. Slices were incubated for ∼30 min
at 37°C and subsequently at room temperature in normal Ringer solution (in mm): 130 NaCl, 3 KCl, 2
MgCl2, 2 CaCl2, 1.25 NaH2PO4, 26 NaHCO3 and 10 glucose. Both substituted and normal Ringer
solutions were bubbled with 95% O2–5% CO2 (extracellular pH (pHo) 7.35).

Slice-patch electrophysiology
Individual slices were transferred to a recording chamber mounted on a fixed-stage microscope (Zeiss
Axioskop FS) and perfused continuously (∼2 ml min−1) with a bath solution of normal Ringer solution
(same as incubation Ringer solution above) bubbled with 95% O2–5% CO2 (pHo 7.35). The pH of the
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bicarbonate-based bath solution was decreased to 6.90 by bubbling with 15% CO2 or 7.10 by bubbling
with 10% CO2. All recordings were made with an Axopatch 200B patch-clamp amplifier, digitized with a
Digidata 1322A A/D converter, and recorded using pCLAMP 10.0 software (Molecular Devices).
Recordings were obtained at room temperature (∼22°C) with patch electrodes pulled from borosilicate
glass capillaries (Warner Instruments) on a two-stage puller (P89; Sutter Instrument) to a DC resistance of
4–6 MΩ when filled with an internal solution containing the following (in mm): 120 KCH3SO3, 4 NaCl, 1
MgCl2, 0.5 CaCl2, 10 Hepes, 10 EGTA, 3 Mg-ATP and 0.3 GTP-Tris (pH 7.2) plus 0.2% biocytin;
electrode tips were coated with Sylgard 184 (Dow Corning). All recordings of neuronal firing rate were
performed in the loose-patch configuration to ensure minimal alteration of the intracellular milieu. Firing
rate histograms were generated by integrating action potential discharge in 10 s bins and plotted using
Spike 5.0 software. Excitatory postsynaptic currents (EPSCs) were measured from chemosensitive
neurons (identified in loose-patch) in whole-cell voltage clamp (Ihold = −60 mV) and analysed off-line
with AxoGraph X using the following parameters: amplitude = −25 pA, rise constant = 0.7 ms and decay
constant = 1.6 ms, with a threshold of detection set to −7 SD.

Drugs
All drugs were purchased from Sigma. For in vivo experiments, the non-specific P2 receptor antagonist
pyridoxalphosphate-6-azophenyl-2′,4′-disulfonic acid (PPADS), the P2Y1-receptor antagonist MRS2179
and the P2Y1-receptor agonist MRS2365 were diluted to 100 μm in sterile saline (pH 7.4) and injected
into the RTN using single-barrel glass pipettes (tip diameter of 20 μm) connected to a pressure injector
(Picospritzer III, Parker Hannifin Corp, Cleveland, OH, USA). For each injection we delivered a volume
of 50 nl over a period of 5 s. These glass pipettes also allowed recordings of field potential properties that
were used to help direct the electrode tip to the desired site. Injections in the RTN region were guided by
recordings of the facial field potential (Brown, Guyenet 1985), and were placed 250 μm below the lower
edge of the field, 1.7 mm lateral to the midline and 200 μm rostral to the caudal end of the field.
Recordings were made on one side only; the second injection was made 1–2 min later at the same level on
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the contralateral side. We included a 5% dilution of fluorescent latex microbeads (Lumafluor, New City,
NY, USA) with all drug applications to mark the injection sites and verify the spread of the injections
(Takakura, Moreira et al. 2011, Takakura, Moreira 2011). For the in vitro experiments, we bath applied
PPADS (100 μm) or suramin (100 μm) to block P2 receptors, MRS2179 (3 μm) to block P2Y1 receptors,
and carbenoxolone (CBX, 100 μm) or cobalt (500 μm) to block gap junction hemichannels. A low Ca 2+,
high Mg2+ synaptic block solution was used to block potential ATP release from neurons and to limit Ca2+
influx into astrocytes from the extracellular space. The composition of the synaptic block medium used in
this study is similar to normal Ringer solution except that MgCl 2 was increased to 11.4 mm, CaCl2 was
decreased to 0.2 mm, and to maintain osmolality, NaCl was decreased to 124 mm. The efficacy of this
synaptic blocking medium is well established (Hatton 1982, Richards, Sercombe 1970, Mason 1980) and
confirmed here by recording its effects on spontaneous EPSCs. In addition, the specific P2Y1 receptor
agonist (MRS2365; 100 μm in Hepes-buffered medium, pH 7.3) was delivered focally using lowresistance pipettes connected to a Picospritzer III (Parker Instrumentation, Cleveland, OH, USA) and
manoeuvered into close proximity of the target neurons. Application times were 600 ms, and vehicle
control experiments were performed to ensure agonist responses were not attributable to pressure
artifacts.

Statistics
Data are reported as mean ± standard error of the mean. Statistical analysis was performed using Sigma
Stat version 3.0 software (Jandel Corporation, Point Richmond, CA, USA). t test, paired t test or one-way
ANOVA followed by the Newman–Keul multiple comparisons test were used as appropriate (P < 0.05).

RESULTS
This study consists of three sets of experiments. First, to determine the extent to which purinergic
signalling contributes to central chemoreception, my collaborators at the University of Sao Paulo tested
the effects of P2 receptor antagonists (PPADS or suramin) on the hypercapnic ventilatory response in
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vivo, and on the firing rate response of RTN neurons to 10% and 15% CO2 at room or body temperature
in vitro. Second, to determine if purinergic drive to RTN neurons is dependent on synaptic input or
requires extracellular Ca2+, as previously reported, I compared effects of P2 receptor antagonists on
neuronal CO2/H+ responsiveness under control conditions and in low Ca2+–high Mg2+ synaptic block
medium. Third, to determine if purinergic drive to CO2/H+-sensitive RTN neurons is mediated by
hemichannels, I tested neuronal CO2/H+ sensitivity in the presence of the gap junction blockers CBX or
cobalt. Note that chemosensitive RTN neurons have been shown to express the transcription factor
Phox2b (Stornetta, Moreira et al. 2006, Lazarenko, Milner et al. 2009); however, Phox2b has also been
shown to be expressed by other cells in relatively close proximity to the RTN, including
catecholaminergic neurons (C1 and A5), facial motor neurons and the superior salivatory nucleus (Kang,
Chang et al. 2007). Therefore, we chose to functionally identify CO2/H+-sensitive RTN neurons based on
their characteristic firing rate response to CO2/H+. Neurons were considered chemosensitive if they were
spontaneously active in 5% CO2 (pHo 7.35) and responded to 15% CO2 (pHo ∼6.90) with at least 1.5 Hz
increase in firing rate. This level of CO2/H+ responsiveness is similar to what we, and others, have
reported for RTN chemosensitive neurons (Ritucci, Erlichman et al. 2005, Wenker, Kreneisz et al. 2010,
Mulkey, Mistry et al. 2006). RTN neurons that did not exhibit this minimum firing rate response to 15%
CO2 were considered non-chemosensitive and excluded from this study.

Purinergic drive to RTN chemoreceptors in vivo
As expected, when urethane-anaesthetized, sino-aortic denervated and vagotomized rats (n = 6 per group)
are exposure to hypercapnia (10% CO2) PNA amplitude and PNA frequency increased by 100 ± 2% and
99 ± 2% (Fig. 7A, D and E). Injections of PPADS (3 mm in 50 nl) were placed bilaterally in the RTN in
these rats (Fig. 7B and C). The injection centre was 250 μm below the facial motor nucleus and 200 μm
rostral to the caudal end of this nucleus, targeting the region that contains the highest density of CO 2sensitive RTN neurons (Mulkey, Stornetta et al. 2004, Takakura, Moreira et al. 2011, Takakura, Moreira
2011). Application of PPADS into the RTN did not change resting PNA activity (99 ± 7% of control
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Figure 7
P2 receptor antagonist injections into the RTN attenuate effects of hypercapnia on arterial pressure
and PNA in anaesthetized vago-sino-aortic denervated rats. A, recordings from one rat showing the
effect of injection of PPADS into the RTN on changes in arterial pressure (AP) and phrenic nerve activity
(PNA) elicited by an increase of end-expiratory CO2 from 5 to 10%. Responses were recorded 10 min
after bilateral injection of saline into the RTN, and 10 min after bilateral injection of PPADS (3 mm, 50 nl
each side) in the RTN. B, photomicrograph of a coronal section showing bilateral injections in the RTN.
Scale bar is 500 μm. C, computer-assisted plot of the centre of injection sites revealed by presence of
fluorescent microbeads included in the injectate (coronal plane at Bregma −11.6; (Paxinos, Watson
1982)). Scale bar is 1 mm. D–F, summary data (n = 6) show changes in PNA amplitude (ΔPNA ampl)
(D), PNA frequency (ΔPNA freq) (E) and mean arterial pressure (ΔMAP) (F) elicited by stepping the
end-expiratory CO2 from 5 to 10% during saline or PPADS injections into the RTN. Differences
expressed as a percentage of the response to the CO2 challenge elicited during saline injection. *Different
from saline (P < 0.05). Abbreviations: py, pyramid; RPa, raphe pallidus; Sp5, spinal trigeminal tract; VII,
facial motor nucleus.
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value; P > 0.05), but did reduce the hypercapnia-induced increase in PNA amplitude (62 ± 9% of the
control) and PNA frequency (77 ± 3% of the control) (Fig. 7D and E). As shown in Fig. 7A, exposure to
hypercapnia also caused hypotension (−11 ± 7 mmHg) followed by a gradual return of mean arterial
pressure (MAP) to control level, 30 to 40 s later. Immediately after hypercapnia ended, the MAP
increased by 21 ± 6 mmHg, and returned to control values within 5 min (Fig. 7A and F). Injection of
PPADS into the RTN did not change resting MAP (124 ± 6 mmHg compared with saline 126 ± 5 mmHg),
but did reduce the hypercapnia-induced pressor response from 21 ± 6 to 8 ± 4 mmHg (Fig. 7A and F).
Injections located outside the RTN region often (3 out of 4) reached the facial motor nucleus or dorsal to
it and one injection (1 out of 4) was located in the parapyramidal region (data not shown). Bilateral
injections of PPADS in the facial motor nucleus or in the parapyramidal region did not change the
hypercapnic-induced respiratory or pressor responses in these animals (data not shown).

Purinergic drive to RTN chemoreceptors in vitro
Previous evidence indicates that temperature greatly increased pH sensitivity of RTN neurons in vitro
(Guyenet, Mulkey et al. 2005). Therefore, we wanted to determine if the contribution of purinergic drive
to CO2/H+-sensitive RTN neurons also increased with temperature. We found that increasing temperature
from ∼22°C to 35°C increased baseline activity by 2.01 ± 0.18 Hz (Fig. 8A) and increased the firing rate
response to 15% CO2 from 1.9 ± 0.09 Hz to 3.3 ± 0.23 Hz (n = 4) (Fig. 8B). The temperature coefficient
(Q10) for the CO2/H+ sensitivity of RTN neurons was estimated to be ∼1.5 ± 0.1 (n = 9); this value is very
similar to the pH-sensitive Q10 of RTN neurons over a similar pH range (∼1.55, extrapolated from Fig.
8D; (Guyenet, Mulkey et al. 2005)]. At 35°C, exposure to the P2 receptor antagonists PPADS (100 μm)
or suramin (100 μm) decreased firing rate by 0.73 ± 0.18 Hz, consistent with the hypothesis that CO 2/H+sensitive RTN neurons receive tonic purinergic input (Wenker, Kreneisz et al. 2010). Prior to testing
CO2/H+ sensitivity at 35°C, a hyperpolarizing current (∼5 pA) was delivered to approximate the control
level of neuronal activity. In the continued presence of PPADS or suramin at 35°C (with baseline activity
adjusted by DC current injection to near-control levels), exposure to 15% CO2 increased neuronal activity
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Figure 8
Purinergic contribution to CO2/H+ sensitivity of RTN neurons is not temperature dependent. A,
traces of firing rate and bath temperature show CO2/H+ responsiveness at room temperature (∼22°C) and
35°C with and without suramin (Sur, 100 μm), a P2 receptor antagonist. At room temperature, increasing
bath CO2 from 5 to 15% increased firing rate ∼2 Hz. Heating to 35°C increased firing rate ∼2 Hz. Prior to
testing CO2/H+ sensitivity at 35°C we delivered a hyperpolarizing current (−5 nA; left arrow) into the cell
to match firing rate to control activity. Under these conditions exposure to 15% CO2 increased firing rate
∼3.5 Hz. A 10 min incubation in suramin (*) decreased the firing rate response to 15% CO2 by 40%.
CO2/H+ sensitivity returned to control levels in wash. B, average data show the CO2/H+-induced firing rate
response at room temperature (a portion of these results were published previously Wenker et al. 2010)
and at 35°C with or without the P2 receptor antagonist PPADS (100 μm, n = 4) or suramin (100 μm, n =
4). Based on these results we calculated the Q10 of CO2/H+ sensitivity and purinergic drive to RTN
neurons to be ∼1.5 and ∼1.3, respectively. C, purinergic drive to chemosensitive RTN neurons shown as
% inhibition of CO2/H+ sensitivity by PPADS (n = 11) or suramin (n = 11) at 22°C and 35°C. Note that
increasing temperature did not increase the purinergic drive to chemosensitive RTN neurons.
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by 2.38 ± 0.23 Hz (n = 8); this response was significantly less than the CO2/H+ response at 35°C in the
absence of the P2 receptor antagonist (initial response or after wash out) (Fig. 8A–B). This purinergicsensitive component of RTN chemoreception has an estimated Q10 of ∼1.3. It is worth noting that this
value is similar to that described for connexin-mediated ATP release or current flux (Q10 = 1.2–1.4;
(Bukauskas, Elfgang et al. 1995, Valiunas, Manthey et al. 1999, Leybaert, Braet et al. 2003). In addition,
heating from 22°C to 35°C did not significantly increase effects of P2 receptor antagonists on CO2/H+
sensitivity of RTN neurons; PPADS and suramin decreased chemoreceptor activity by 27.3 ± 4.8% (n =
12) and 27.9 ± 4.5% (n = 8) at 22°C and 35°C, respectively (Fig. 8C). These results indicate that
purinergic drive to CO2/H+-sensitive RTN neurons does not vary over this temperature range; therefore,
all subsequent in vitro experiments were performed at room temperature.

To address the possibility that purinergic drive to RTN neurons is stimulus dependent, we compared
effects of suramin on the firing rate response of RTN neurons to 10% and 15% CO2. As shown in Fig. 9A
and B, exposure to 10% (pHo 7.10) and 15% CO2 (pHo 6.90) increased chemoreceptor activity by 1.83 ±
0.17 Hz and 2.48 ± 0.20 Hz (n = 3), respectively. In addition, suramin had similar effects on the firing rate
response of RTN neurons to 10% and 15% CO2. Previous (Wenker, Kreneisz et al. 2010) and current
results (Fig. 9C and D) show that ∼10 min incubation in suramin (100 μm) decreased the response of
RTN neurons to 10% and 15% CO2 by 33.5 ± 3.3% and 31.9 ± 7.2%, respectively (Fig. 9C and D),
suggesting that purinergic drive to these cells is relatively constant over this CO2 range.

Changes in the extracellular Ca2+ gradient do not affect purinergic drive to chemoreceptors
Evidence suggests that H+-evoked ATP release triggers Ca2+ influx into ventral surface astrocytes,
possibly via P2X receptors, and this leads to bulk ATP release and subsequent activation of CO2/H+sensitive RTN neurons (Gourine, Kasymov et al. 2010)). To explore this possibility further, we tested the
effects of a high MgCl2 and low CaCl2 medium on the CO2/H+ sensitivity of RTN neurons. We used low
(200 μm) rather than zero Ca2+ in order to minimize the effects of low Ca2+ on gap junctions. In addition,
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Figure 9
Purinergic drive does not increase with increased CO2 intensity. A, firing rate trace shows that
exposure to 10 and 15% CO2 increased neuronal activity by 2.9 and 2.1 Hz, respectively. In the presence
of suramin (100 μm), exposure to 10% CO2 increased neuronal activity only 1.6 Hz. Responsiveness to 10
and 15% CO2 was fully recovered when suramin was washed out. The asterisks denote 10 min time
breaks. B, average data (n = 3) show that exposure to 10 and 15% CO2 increased neuronal activity in a
relatively linear manner. C, summary data (n = 3) show that suramin decreased the firing rate response to
10% CO2. D, summary data (n = 3) show that suramin decreased the responsiveness to 10 and 15% CO2
by similar amounts, indicating that purinergic drive to chemosensitive RTN neurons does not increase in
response to this range of stimulus intensities.
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this medium has been shown to effectively block Ca2+-dependent exocytosis with little disruption of
intrinsic membrane characteristics (Richards, Sercombe 1970). As before, CO2/H+-sensitive RTN neurons
were identified based on their robust firing rate response to 15% CO2 in normal Ringer solution. Exposure
to low Ca2+–high Mg2+ medium alone did not consistently increase baseline activity, suggesting that this
low level of extracellular Ca2+ did not facilitate gap junction-mediated ATP release. However, as noted
below low Ca2+–high Mg2+ medium can inhibit excitatory input to RTN chemoreceptors (Fig. 10C), and
so potentially offset excitatory effects of connexin-mediated ATP release. A second exposure to 15%
CO2, this time after ∼10 min incubation in low Ca2+–high Mg2+ solution, also elicited a strong firing rate
response (Fig. 10A and B), indicating that a 10-fold decrease in the extracellular Ca2+ gradient did not
affect CO2/H+ sensitivity (Fig. 10B). To confirm that Ca2+-dependent exocytosis was effectively
attenuated by these incubation conditions, we recorded excitatory post-synaptic currents (EPSCs) from
RTN chemoreceptor neurons during exposure to the low Ca2+–high Mg2+ solution. As expected, ∼5 min
perfusion with low Ca2+–high Mg2+ solution caused a robust and reversible decrease in EPSC frequency
with only a modest effect on amplitude (Fig. 10C–E). These results suggest that the CO2/H+ sensitivity of
RTN neurons, including the purinergic component, is not dependent on neuronal vesicle release.

Gap junction hemichannels contribute to CO2/H+-evoked ATP release in the RTN
There is evidence that connexin 26 hemichannels are directly gated by CO2 (Huckstepp, Eason et al.
2010) and contribute to CO2-evoked ATP release in the RTN (Huckstepp, id Bihi et al. 2010). To test
whether connexin-mediated transmitter release contributes to the CO2/H+ sensitivity of RTN neurons, we
used CBX and cobalt to block hemichannels. We found that ∼10 min incubation in CBX (100 μm)
decreased neuronal CO2/H+ sensitivity by 0.74 ± 0.18 Hz (n = 6) or 27.7 ± 5.5% (Fig. 11A and B).
Likewise, incubation in cobalt (500 μm) decreased neuronal CO2/H+ sensitivity by 0.64 ± 0.08 Hz (n = 5)
or 26.36 ± 2.73% (Fig. 11C and D). Note that both gap junction blockers decreased neuronal CO2/H+
sensitivity by an amount similar to the previously reported effects of P2 receptor antagonists (PPADS and
suramin); at room temperature P2 receptor antagonists decreased CO2/H+ sensitivity of RTN neurons by
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Figure 10
Purinergic drive to RTN neurons is not dependent on extracellular Ca2+. A, firing rate trace shows
that the CO2/H+ sensitivity of an RTN neuron was unaffected by low Ca2+–high Mg2+ synaptic block (SB)
medium. The asterisks denote 8 min time breaks. B, average data (n = 5) show that SB medium did not
significantly affect CO2/H+ sensitivity (P = 0.982). C, traces of holding current (at a potential of −60 mV)
show that exposure to SB medium blocked spontaneous excitatory post-synaptic currents (EPSCs) in
chemosensitive RTN neurons. D and E, as expected, SB medium inhibited EPSC frequency (D, n = 3) but
not EPSC amplitude (E, n = 3). Average decay time constant was 4.8 ± 0.2 ms (not shown). These results
suggest that extracellular Ca2+ is not required for the purinergic drive to breathe.
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Figure 11
Gap junction blockers decrease purinergic drive to RTN neurons. A, trace of firing rate shows that
under control conditions, exposure to 15% CO2 increased the neuronal activity ∼3 Hz. A second exposure
to 15% CO2, this time after 10 min incubation with carbenoxolone (CBX, 100 μm), increased firing rate
only ∼2 Hz. The asterisk indicates a gap in recording during the CBX wash. B, average data (n = 6) show
that CBX decreased CO2/H+ sensitivity by ∼30%. C, trace of firing rate shows that exposure to 15% CO2
increased neuronal activity 2.1 Hz. After returning to control conditions, exposure to cobalt (500 μm)
inhibited neuronal activity; therefore a depolarizing current (5 nA; arrow) was injected into the cell to
approximate baseline activity under control conditions. In the continued presence of cobalt (with a
holding current of 5.0 nA), a second exposure to 15% CO2 this time only increased firing rate ∼1.5 Hz.
CO2 responsivness was fully recovered after washing out cobalt for ∼10 min. D, average data (n = 5)
show that cobalt decreased CO2/H+ sensitivity by ∼30%.
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0.7 ± 0.18 Hz or 27.3 ± 4.8% (Wenker, Kreneisz et al. 2010). Furthermore, in combination suramin and
cobalt decreased CO2/H+ sensitivity of RTN neurons by 28 ± 3.0% (Fig. 12A and B). The per cent
inhibition by suramin and cobalt acting together was not different from that of either blocker alone (Fig.
12C), further suggesting that the majority of CO2-evoked ATP release is mediated by gap junction
hemichannels. Together, these results strongly suggest that gap junction hemichannels mediate CO2evoked ATP release in the RTN.

P2Y1 receptors in the RTN do not contribute to central chemoreception in vitro or in vivo
Evidence suggests that P2Y receptors mediate the excitatory effects of ATP on CO2/H+-sensitive RTN
neurons (Mulkey, Mistry et al. 2006, Wenker, Kreneisz et al. 2010). Of these, P2Y1 receptors have been
shown to function as the primary substrate for ATP-mediated activation of inspiratory neurons in the
preBötzinger complex (Lorier, Lipski et al. 2008, Lorier, Huxtable et al. 2007), a region critically
involved in inspiratory rhythm generation (Smith, Ellenberger et al. 1991). Therefore, we considered the
possibility that P2Y1 receptors also contribute to up-stream purinergic modulation of CO2/H+-sensitive
RTN neurons. To make this determination, we tested effects of MRS2179 (a potent and specific P2Y1
receptor blocker) on CO2 sensitivity of RTN neurons in vitro and in vivo. In the brain slice preparation,
incubation (∼10 min) in MRS2179 (3 μm) had negligible effects on baseline activity and CO2/H+
sensitivity of RTN neurons (Fig. 13A and B). In addition, focal application of a specific P2Y1 receptor
agonist (MRS2365, 100 μm) had no effect on activity of CO2/H+-sensitive RTN neurons (Fig. 13A).
These results suggest P2Y1 receptors are not expressed by CO2/H+-sensitive RTN neurons and do not
contribute to their CO2 sensitivity.

To determine if P2Y1 receptors contribute to CO2-induced changes in breathing or blood pressure in vivo,
we measured CO2 responsivness after bilateral RTN injections of saline or MRS2179. As described
above, under control conditions (i.e. after saline injections), exposure to hypercapnia (10% CO2) increases
PNA and causes hypotension (−16 ± 6 mmHg) followed by an increase in MAP (24 ± 5 mmHg) (Figs 7
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Figure 12
In combination, P2 receptor antagonist and gap junction blockers decrease CO 2/H+ sensitivity by
an amount similar to each blocker alone. A, trace of firing rate shows that under control conditions
exposure to 15% CO2 increased neuronal activity ∼2 Hz. A second exposure to 15% CO2, this time in the
presence of suramin to block P2 receptors and cobalt to block gap junction hemichannels, increased firing
rate only ∼1 Hz or 72% of control. The asterisk indicates an 8 min time break. CO2 sensitivity fully
recovered after washing out suramin and cobalt. B, summary data (n = 3) show that in combination
suramin and cobalt decreased CO2/H+ sensitivity of RTN neurons by 28 ± 3.0%. C, the per cent inhibition
by suramin and cobalt acting together is not different from that of either blocker alone.
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Figure 13
Purinergic drive to RTN neurons does not depend on P2Y1 receptors. A, trace of firing rate shows
that under control conditions exposure to 15% CO2 increased neuronal activity ∼3 Hz. A second exposure
to 15% CO2, this time in the presence of the P2Y1 receptor-specific antagonist MRS2179 (3 μm), also
increased firing rate by ∼3 Hz. The asterisk indicates a 10 min time break during which the tissue was
incubated in MRS2179. Arrows indicate when the P2Y1-specific agonist MRS2365 (100 μm in 7.3 Hepes
buffer) was focally applied. B, summary data (n = 6) show that MRS2179 had no effect on the CO2/H+
sensitivity of RTN neurons.

66

67

and 14). Bilateral RTN injections of MRS2179 (100 μm in 50 nl) did not change resting MAP (119 ± 5
mmHg compared with saline 121 ± 3 mmHg) or baseline PNA activity (102 ± 5% of control). In addition,
injections of MRS2179 did not affect the CO2-induced pressor response (24 ± 5 mmHg vs. saline 19 ± 4
mmHg) or the CO2-induced increase in PNA amplitude (86 ± 15% of control) and PNA frequency (108 ±
5% of the control) (Fig. 14A and C–E). However, unilateral RTN injections of MRS2365 (100 μm in 50
nl) increased MAP by 23 ± 1 mmHg (compared with 4 ± 1 mmHg in control experiments) and increased
PNA amplitude and frequency by 59 ± 6% and 53 ± 5%, respectively (Fig. 15C–E). Further, bilateral
injections of MRS2179 entirely blocked the effects of MRS2365 (Fig. 15A–E), thus confirming
effectiveness of the antagonist. These results are consistent with our in vitro evidence that P2Y1 receptors
are not expressed by CO2/H+-sensitive RTN neurons and do not contribute to central CO2 sensitivity.

DISCUSSION
There is compelling evidence that CO2-evoked ATP release from ventral surface astrocytes contributes to
respiratory drive by activating chemosensitive RTN neurons (Gourine, Kasymov et al. 2010, Gourine,
Llaudet et al. 2005, Wenker, Kreneisz et al. 2010). Here, we demonstrate in vivo that blocking P2
receptors in the RTN lessened the changes in PNA amplitude, PNA frequency and pressor responses
elicited by central chemoreflex activation. Additionally, we show in vitro that bath application of P2
receptor antagonists (PPADS and suramin) blunted the firing rate response of RTN neurons to 10% and
15% CO2 by 30%. We show that the contribution of purinergic signalling to chemosensitive RTN
neuronal activity is independent of temperature and stimulus strength. These results clearly indicate that
purinergic signalling contributes in part to the integrated output of the RTN during hypercapnia. We also
found that the purinergic drive to chemosensitive RTN neurons was wholly retained in low Ca 2+ synaptic
block medium but was significantly attenuated by gap junction blockers (CBX and cobalt), suggesting
that astrocytes release ATP via gap junction hemichannels. Our results also show that P2Y1 receptors do
not contribute to CO2/H+ sensitivity of the RTN; however, P2Y1 receptors are expressed in the region and
their activation can influence respiratory and sympathetic outflow of the RTN. The identity and function
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Figure 14
P2Y1 receptors do not contribute to CO2-induced changes in breathing or blood pressure. A, traces
of end-expiratory CO2 (etCO2), arterial pressure (AP) and integrated PNA (iPNA) show CO2 responses 10
min after RTN injections of saline or MRS2179 (100 μm, 50 nl each side). B, computer-assisted plot of
the centre of injection sites (Bregma −11.6; Paxinos & Watson, 1998). Scale bar in B, 1 mm. C–E,
summary data (n = 5) showing changes in mean arterial pressure (ΔMAP) (C), PNA amplitude (ΔPNA
ampl) (D) and PNA frequency (ΔPNA freq) (E) elicited by stepping the end-expiratory CO2 from 5 to
10% after RTN injections of saline or MRS2179. Differences are expressed as a percentage of the
response to CO2 after saline injection. Abbreviations: py, pyramid; RPa, raphe pallidus; Sp5, spinal
trigeminal tract; VII, facial motor nucleus.
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Figure 15
RTN injections of a specific P2Y1 agonist increased arterial pressure and PNA in anaesthetized
vago-sino-aortic-denervated rats. A, traces of arterial pressure (AP) and integrated phrenic nerve
activity (iPNA) show that unilateral RTN injections of the specific P2Y1 receptor agonist MRS2365 (100
μm in 50 nl) increased AP and PNA. B, computer-assisted plot of injection sites (coronal plane at Bregma
−11.6 (Paxinos & Watson, 1998). Scale bar in B, 1 mm. C–E, summary data (n = 6) show MRS2365induced ΔMAP (B), ΔPNA amp (C) and ΔPNA freq (D) after RTN injections of saline or MRS2179.
Differences expressed as a percentage of the response to the CO2 challenge elicited during saline
injection. Abbreviations: py, pyramid; Sp5, spinal trigeminal tract; VII, facial motor nucleus.
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of these P2Y1-expressing neurons remain unknown. We conclude that RTN chemoreception is
determined primarily by CO2/H+-sensitive neurons but is augmented by gap junction-mediated, CO2evoked ATP release most probably from astrocytes.

Experimental limitations
Our in vivo experiments were performed is anaesthetized rats and it is well known that anaesthetics can
modify centrally mediated cardio-respiratory reflexes. Therefore, it will be important for future studies to
confirm the role of purinergic signalling in central chemoreception using conscious animals. In addition,
we did not measure ATP directly but rather used the activity of RTN chemoreceptors as a functional
measure of ATP release. This approach is reasonable considering that CO2-evoked ATP release in the
region of the RTN is well established (Gourine, Kasymov et al. 2010, Gourine, Llaudet et al. 2005,
Huckstepp, id Bihi et al. 2010) and the focus of the current study is on the purinergic drive to RTN
neurons, which has received only limited attention. This study was also limited by the lack of
pharmacological tools that allow for the specific manipulation of astrocytes without confounding effects
on neurons. Nevertheless, the results presented here provide important direction for future experiments
that take advantage of astrocyte-specific transgenic animal models, e.g. IP3-receptor type 2 (IP3R2)
knockout mice (Petravicz, Fiacco et al. 2008) or the dominant negative synaptobrevin 2 model (Pascual,
Casper et al. 2005), to further dissect neuron–astrocyte interactions in the context of chemoreception.

Contribution of purinergic signalling to RTN chemoreception
Bilateral injection of PPADS into the RTN of adult rats decreased the ventilatory response to CO 2 by
∼30%. These results are entirely consistent with previous evidence showing that direct application of
PPADS onto the exposed ventral surface also decreased the hypercapnic ventilatory response in vivo by
up to ∼30% (Gourine, Llaudet et al. 2005). In addition, we show by using brain slices from neonatal rat
pups that bath application of PPADS or suramin decreased the response of functionally identified
CO2/H+-sensitive RTN neurons by ∼30% regardless of stimulus strength or bath temperature.
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Considering that P2 receptor blockers had similar effects on chemosensitivity in neonatal (postnatal days
7–12) and adult rats suggests that the purinergic drive to RTN neurons does not increase over this age
range. However, astrocyte are known to undergo dramatic changes during the first postnatal week, and in
other brain regions it is not until ∼day 4 that characteristically mature astrocytes first appear (i.e.
electrically passive) (Zhou, Schools et al. 2006). In the RTN, CO2/H+-sensitive astrocytes exhibit an
electrically passive signature and presumably these cells are the source of ATP released in this region
during hypercapnia (Wenker, Kreneisz et al. 2010). Therefore, if mature astrocytes are absent from the
RTN in newborn animals, than we expect CO2/H+ sensitivity to be determined exclusively by intrinsic
neuronal properties. This is exactly what (Onimaru, Ikeda et al. 2012) demonstrated using the in vitro
brainstem–spinal cord preparation from newborn rats; bath application of P2 receptor blockers (MRS2179
or PPADS) had no effect on CO2 responsivness of pFRG/RTN neurons. Our results clearly show in
neonatal and adult rats that CO2-evoked ATP release contributes to a portion of the hypercapnic
ventilatory response by increasing baseline activity of chemosensitive RTN neurons at any given level of
CO2. However, it remains questionable whether purinergic signalling directly contributes to the H +sensing mechanism of RTN neurons. In addition, the purinergic-independent component of RTN
chemoreception (∼70%) was retained when synaptic activity was blocked which strengthens the
possibility that RTN neurons are CO2/H+ sensitive (Mulkey, Mistry et al. 2006).

It is well established that hypercapnia produces biphasic changes in vascular tone, i.e hypotension
followed by hypertension. The initial hypotension probably results from a direct effect of CO 2/H+ on
vasculature smooth muscle cells. Compensatory activation of sympathetic activity allows arterial pressure
to recover to near control levels during hypercapnia, and accounts for the increase in arterial pressure
observed at the end of the hypercapnia episode (Takakura, Moreira 2011, Mulkey, Mistry et al. 2006).
Application of PPADS into the RTN region decreased the sympathetic-mediated pressure response to
hypercapnia, suggesting a novel role of purinergic signalling in regulation of vascular tone during
hypercapnia. For example, it is possible that CO2-evoked ATP release provides excitatory drive to the
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nearby RVLM/C1 presympathetic neurons. In the presence of PPADS this excitatory drive would be
reduced and so potentially decrease sympathetic output. However, this possibility remains speculative and
in need of further investigation.

The identity of P2 receptors expressed by CO2/H+-sensitive RTN neurons remains unknown. It was
shown previously that P2Y1 receptors mediate the excitatory effects of ATP on neurons in the
preBötzinger complex (Lorier, Lipski et al. 2008, Lorier, Huxtable et al. 2007). However, we found that
P2Y1 receptors are not expressed by chemosensitive RTN neurons and do not contribute to CO2/H+
sensitivity of these cells in vitro or to CO2-induced changes in breathing or blood pressure in vivo.
Therefore, P2Y1 receptors do not contribute to RTN chemoreception. However, activation of P2Y1
receptors in the RTN increased breathing and MAP, suggesting that P2Y1 receptors are expressed in the
region and, when activated, can influence respiratory and sympathetic outflow. Considering that ADP not
ATP is the preferential ligand for P2Y1 receptors, we speculate that ATP released during hypercapnia is
not readily broken down to ADP and adenosine, thus limiting the contribution of these unknown P2Y1expressing neurons to regulation of breathing or blood pressure. A focus of future work will be to
determine the identity and function of these P2Y1-expressing RTN neurons. Nevertheless, the absence of
an identifiable G-protein-coupled purinergic receptor on chemosensitive RTN neurons suggests that one
or more P2X receptors may contribute to purinergic modulation of chemosensitive RTN neurons,
possibly P2X1 and/or P2X3 (Gourine, Kasymov et al. 2010).

Requisite role of gap junction hemichannels in purinergic drive to RTN chemoreceptors
Our evidence that gap junction blockers (CBX and cobalt), but not synaptic block medium, decreased
chemosensitive RTN neuronal activity by an amount proportional to inhibition by P2 receptor
antagonists, suggests that the purinergic drive to RTN neurons is dependent on hemichannels. We
consider it unlikely that communication between astrocytes via gap junctions is a major determinant of
purinergic drive to neurons in this region for two reasons. First, RTN astrocytes are unusual in that they
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exhibit limited dye-coupling compared with astrocytes in other brain regions (Wenker, Kreneisz et al.
2010), suggesting that these cells are not extensively gap junction coupled. In addition, previous evidence
showed that cobalt preferentially blocks hemichannel current with little effect on transjunctional current
through gap junctions in embryonic stem cells (Huettner, Lu et al. 2006). Our results are consistent with a
recent in vivo study that showed that application of connexin hemichannel antagonists near the RTN
inhibited CO2-evoked ATP release and decreased the whole animal ventilatory response to CO2 by ∼25%
(Huckstepp, id Bihi et al. 2010).

There is convincing evidence that CO2-evoked ATP release in the RTN is dependent on connexin 26
(Cx26) (Huckstepp, Eason et al. 2010). The mechanism by which CO2 influences the gating of Cx26
hemichannels is not fully understood. Evidence suggests that molecular CO2 binds directly to Cx26 to
increase the open probability of the hemichannel (Huckstepp, Eason et al. 2010). However, it has also
been shown that CO2/H+ sensitivity of RTN astrocytes is determined, in part, by inhibition of Kir4.1–
Kir5.1 channels (Wenker, Kreneisz et al. 2010), suggesting that membrane depolarization could trigger
ATP release. This mechanism could be parsimonious with the current data considering that certain
hemichannels exhibit voltage-dependent gating (Saez, Retamal et al. 2005). However, rat Cx26 does not
demonstrate voltage dependence (Gonzalez, Gomez-Hernandez et al. 2006); thus, if Cx26 is the main
conduit for ATP release from RTN astrocytes then acid-induced changes in membrane potential might not
contribute. Consistent with this possibility, a recent in vivo study reported that Kir5.1 knockout mice
exhibit normal ventilatory response to CO2 in vivo (Trapp, Tucker et al. 2011), suggesting that astrocytic
membrane depolarization is not required for CO2-evoked ATP release. However, it should be recognized
that Kir5.1 channels are expressed in other organs, including the kidneys, and as described by Trapp et al.
these conventional knockout mice have profound metabolic acidosis which could conceivably interfere
with this acid-sensing mechanism. Thus, the link between CO2/H+-induced changes in astrocytic
membrane potential and ATP release remains to be definitively established.
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Role of astrocytes in RTN purinergic signalling
There is general agreement that astrocytes (or more precisely glial-like cells that express astrocytic
markers) are the most likely source of ATP release (Wenker, Kreneisz et al. 2010, Gourine, Kasymov et
al. 2010). For example, Gourine and colleagues demonstrated, using astrocyte-specific expression of
channel rhodopsin 2, a light-sensitive cation channel, that generating calcium waves in astrocytes results
in ATP release that can activate RTN neurons in vitro and increase breathing in vivo (Gourine, Kasymov
et al. 2010). Likewise, we have shown that fluorocitrate-mediated activation of astrocytes resulted in
increased activity of chemosensitive RTN neurons by a purinergic-dependent mechanism (Wenker,
Kreneisz et al. 2010). In addition, Huckstepp and colleagues showed that hypercapnia opened connexin
hemichannels on glial fibrillary acidic protein (GFAP)-expressing cells (Huckstepp, Eason et al. 2010),
thus suggesting that direct CO2 gating of connexin hemichannels results in ATP release from astrocytes.
We show here that CO2 sensitivity of RTN neurons is fully retained in low Ca2+–high Mg2+ solution, thus
further suggesting that that purinergic drive to RTN neurons is not dependent on excitatory synaptic
transmission.
In summary, the RTN contains a population of CO2/H+-sensitive neurons that sends excitatory
glutamatergic projections to respiratory centres to stimulate breathing and modulate sympathetic drive to
the heart and vasculature (Takakura, Moreira 2011, Moreira, Takakura et al. 2006). In addition to
activation by CO2/H+, RTN neurons are also modulated by various neurotransmitters, including ATP
(Mulkey, Mistry et al. 2006, Gourine, Kasymov et al. 2010, Wenker, Kreneisz et al. 2010). Based on
previous and present results, astrocytes (but not neurons) most probably mediate CO2-evoked ATP release
by a mechanism involving gap junction hemichannels.
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Chapter 6 Purinergic signaling contributes to chemoreception at the level of the retrotrapezoid
neucleus but not the nucleus of the solitary tract or medullary raphe.

INTRODUCTION
Hypercapnic acidosis (i.e., high CO2/H+) provides the primary stimulus to breathe. Central respiratory
chemoreceptors sense changes in tissue CO2/H+ and send excitatory drive to respiratory centers to directly
regulate depth and frequency of breathing (Feldman, Mitchell et al. 2003, Huckstepp, Dale 2011). The
process of chemoreception is especially important during sleep and its disruption has been associated with
central sleep apnea and hypoventilation syndrome (Dempsey, Smith et al. 2012, Guyenet, Mulkey 2010).
Nevertheless, despite the importance of central chemoreceptors the cellular and molecular mechanism(s)
underlying this process have yet to be fully elucidated.

Several brain regions are thought to function as important sites of chemoreception including the
commissural portion of the nucleus of the solitary tract (commNTS) (Dean, Bayliss et al. 1990, Li, Nattie
2002), medullary raphe (e.g., raphe pallidus, magnus and obscurus) (Hodges, Martino et al. 2004, Nattie,
Li 2001, Richerson 2004, Wang, Richerson 1999) and retrotrapezoid nucleus (RTN) (Li, Nattie 2002,
Wang, Shi et al. 2013, Mulkey, Stornetta et al. 2004). Of these, the mechanism(s) of chemotransduction
are best characterized at the level of the RTN where neurons have been shown to sense changes in
CO2/H+ by two independent but coordinated mechanisms: direct H+-mediated activation of pH-sensitive
neurons by inhibition of a resting K+ conductance (Mulkey, Stornetta et al. 2004, Mulkey, Talley et al.
2007), and indirect activation by purinergic signaling most likely from CO2/H+-sensitive astrocytes
(Gourine, Llaudet et al. 2005, Huckstepp, id Bihi et al. 2010, Mulkey, Mistry et al. 2006, Wenker,
Kreneisz et al. 2010, Wenker, Sobrinho et al. 2012). Evidence also suggests that purinergic signaling is a
unique feature of RTN chemotransduction. For example, it was shown in vivo that CO2/H+ facilitates
ATP release only at discrete locations near the RTN (Gourine, Llaudet et al. 2005) , and RTN astrocytes,
but not cortical astrocytes respond to H+ with increased Ca2+-dependent exocytosis of ATP-containing
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vesicles (Kasymov, Larina et al. 2013).

However, the role of purinergic signaling in putative

chemoreceptor regions outside the RTN has not been thoroughly investigated.

Indeed, it remains possible that purinergic signaling also regulates neuronal activity in other putative
chemosensitive regions. For example, P2-receptors are widely distributed throughout the central nervous
system including in the NTS and medullary raphe (Yao, Barden et al. 2000). In addition, injections of
ATP into the commNTS increased breathing (Antunes, Braga et al. 2005), whereas application of a P2receptor blocker to the NTS blunted peripheral chemoreflex control of cardiorespiratory function (Paton,
De Paula et al. 2002).. Furthermore, injection of ATP into the medullary raphe increased breathing (Cao,
Song 2007), whereas injection of a P2-receptor blocker into the rostral medullary raphe blunted the
ventilatory response to CO2 of conscious rats (da Silva, Moraes et al. 2012). These results suggest that
purinergic signaling may contribute to the CO2/H+-dependent drive to breathe at other putative
chemoreceptor regions. Therefore, the main goal of this study is to determine at the cellular and system
levels whether purinergic signaling contributes to CO2/H+-sensitivity in the commNTS and medullary
raphe

To test this possibility, we recorded activity of individual CO2/H+-sensitive neurons in putative
chemosensitive regions in vitro, and phrenic nerve activity (PNA) in vivo during exposure to hypercapnia
alone and in the presence of P2 receptor blockers. To determine if cells in the regions of interest
functionally express P2-receptors, we also tested responsiveness to exogenous application of ATP in vivo
and in vitro. In addition, we performed a set of immunohistochemical experiments using the astrocyte
specific marker aldehyde dehydrogenase (Aldh1L1) to determine the distribution of astrocytes in the
commNTS, medullary raphe and RTN. We find in vitro that CO2/H+-sensitive neurons in the commNTS
respond to focal ATP application with ~3 fold increase in firing rate, and in vivo unilateral ATP injection
into this region elicited an increase in PNA by ~81%. Application of ATP into the medullary raphe had
no effect on chemoreceptor activity or cardiorespiratory output. In addition, P2 receptor blockade in the
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commNTS and medullary raphe had no effect on the ventilatory response to CO2 in vivo, or the firing rate
response to 15% CO2 in vitro.

Furthermore, we find that astrocytes are underrepresented in the

commNTS and medullary raphe as compared to the RTN.

In conjunction with previous data that

purinergic signaling is a critical component of RTN chemoreception, these results indicate that purinergic
signaling is a unique feature of RTN chemoreception.

METHODS
In vivo preparation
All in vivo experiments conformed to the guidelines approved by the University of São Paulo Animal
Care and Use Committee. All in vivo experiments were performed in male Wistar rats weighing 250-280
g. Surgical procedures and experimental protocols were similar to those previously described (Wenker,
Sobrinho et al. 2012). Briefly, general anesthesia was induced with 5% halothane in 100% O2. A
tracheostomy was made and the halothane concentration was reduced to 1.4-1.5% until the end of
surgery. The femoral artery was cannulated (polyethylene tubing, 0.6 mm o.d., 0.3 mm i.d., Scientific
Commodities, Lake Havasu City, Arizona, USA) for measurement of arterial pressure (AP). The femoral
vein was cannulated for administration of fluids and drugs. The occipital plate was removed, and a
micropipette was placed in the medulla oblongata via a dorsal transcerebellar approach for microinjection
of drugs. A skin incision was made over the lower jaw for placement of a bipolar stimulating electrode,
next to the mandibular branch of the facial nerve, as previously described (Wenker, Sobrinho et al. 2012).
The phrenic nerve was accessed by a dorsolateral approach after retraction of the right shoulder blade. To
prevent any influence of artificial ventilation on phrenic nerve activity (PNA), the vagus nerve was cut
bilaterally as follows.

Upon completion of the surgical procedures, halothane was replaced by urethane (1.2 g/kg) administered
slowly i.v. All rats were ventilated with 100% O2 throughout the experiment. Rectal temperature was
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maintained at 37°C. End-tidal CO2 was monitored throughout each experiment with a capnometer (CWE,
Inc, Ardmore, PA, USA) that was calibrated twice per experiment with a calibrated CO2/N2 mix. This
instrument provided a reading of <0.1% CO2 during inspiration in animals breathing 100% O2 and
provided an asymptotic, nearly horizontal reading during expiration. The adequacy of anesthesia was
monitored during a 20 min stabilization period by testing for the absence of withdrawal responses, pressor
responses, and changes in PNA to a firm toe pinch. After these criteria were satisfied, the muscle relaxant
pancuronium was administered at an initial dose of 1 mg/kg i.v. and the adequacy of the anesthesia was
thereafter gauged solely by the lack of increase in AP and PNA rate or amplitude to a firm toe pinch.
Approximately hourly supplements of one-third of the initial dose of urethane were needed to satisfy
these criteria throughout the recording period (2-3 hours).

In vivo recordings of physiological variables
As previously described, mean arterial pressure (MAP), phrenic nerve activity (PNA), and end-expiratory
CO2 (etCO2) were digitized with a micro1401 (Cambridge Electronic Design), stored on a computer, and
processed off-line with version 6 of Spike 2 software (Cambridge Electronic Design, Cambridge, UK).
Integrated phrenic nerve activity (iPNA) was obtained after rectification and smoothing (τ = 0.015s) of
the original signal, which was acquired with a 30-300 Hz bandpass filter. PNA amplitude (PNA amp) and
PNA frequency (PNA freq) were normalized in each experiment by assigning to each of the two variables
a value of 100 at saturation of the chemoreflex (high CO2) and a value of 0 to periods of apnea.

Brain slice preparation
All procedures were performed in accordance with National Institutes of Health and University of
Connecticut Animal Care and Use Guidelines. Brainstem slices were prepared as previously described
(Wenker, Sobrinho et al. 2012). Briefly, neonatal rats (7-12 days postnatal) were decapitated under
ketamine/xylazine anesthesia and transverse brainstem slices (300 μm) containing the raphe pallidus
(RPa) were cut using a microslicer (DSK 1500E; Dosaka, Kyoto, Japan) in ice-cold substituted Ringer
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solution containing (in mM): 260 sucrose, 3 KCl, 5 MgCl2, 1 CaCl2, 1.25 NaH2PO4, 26 NaHCO3, 10
glucose, and 1 kynurenic acid. Slices were incubated for ~30 min at 37°C and subsequently at room
temperature in normal Ringer solution (in mM): 130 NaCl, 3 KCl, 2 MgCl2, 2 CaCl2, 1.25 NaH2PO4, 26
NaHCO3, and 10 glucose. Both substituted and normal Ringer solutions were bubbled with 95% O2-5%
CO2, extracellular pH (pHo = 7.35). It should be noted that slices containing the commNTS were
prepared as described above but with two exceptions: 1) slices were cut in normal Ringer solution (not
substituted ringers); and 2) slices were incubated at room temperature (not 37°C) for 60 minutes or more.

Slice-patch electrophysiology
Individual slices were transferred to a recording chamber mounted on a fixed-stage microscope (Zeiss
Axioskop FS) and perfused continuously (~2 ml min−1) with a bath solution of normal Ringer solution
(same as incubation Ringers above) bubbled with 95% O2-5% CO2 (pHo = 7.35). The pH of the
bicarbonate-based bath solution was decreased to 6.90 by bubbling with 15% CO2. All recordings were
made with an Axopatch 200B patch-clamp amplifier, digitized with a Digidata 1322A A/D converter, and
recorded using pCLAMP 10.0 software (Molecular Devices). Recordings were obtained at room
temperature (~22 ºC) with patch electrodes pulled from borosilicate glass capillaries (Warner
Instruments) on a two-stage puller (P89; Sutter Instrument) to a DC resistance of 4–6 MΩ when filled
with an internal solution containing the following (in mM): 120 KCH3SO3, 4 NaCl, 1 MgCl2, 0.5 CaCl2,
10 HEPES, 10 EGTA, 3 Mg-ATP, 0.2% biocytin, and 0.3 GTP-Tris (pH 7.2); electrode tips were coated
with Sylgard 184 (Dow Corning). All recordings of neuronal firing rate were performed in the cellattached configuration to ensure minimal alteration of the intracellular milieu. Firing rate histograms were
generated by integrating action potential discharge in 10-s bins and plotted using Spike 5.0 software.
Whole cell voltage clamp recordings (Ihold = -60 mV, in tetrodotoxin to block action potentials) were
made to verify the serotonergic phenotype of RPa neurons; i.e., medullary raphe neurons are known to
exhibit a serotonin-activated inward potassium conductance (Bayliss, Li et al. 1997).
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Drugs
All drugs were purchased from Sigma unless otherwise indicated. For in vivo experiments, the nonspecific P2-receptor antagonist pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid (PPADS) was
diluted to 100 µM in sterile saline (pH 7.4) or ATP (10 mM) and injected into the RTN using singlebarrel glass pipettes (tip diameter of 25 µm) connected to a pressure injector (Picospritzer III, Parker
Hannifin Corp, Cleveland, OH). For each injection we delivered a volume of 50 nl over a period of 5s.
These glass pipettes also allowed recordings of field potential properties that were used to help direct the
electrode tip to the desired site. Injections in the RTN region were guided by recordings of the facial field
potential (Brown, Guyenet 1985), and were placed 250 μm below the lower edge of the field, 1.7 mm
lateral to the midline, and 200 μm rostral to the caudal end of the field. Recordings were made on one side
only; the second injection was made 1-2 min later at the same level on the contralateral side. Injections
into the medullary raphe were placed in the raphe pallidus (N= 6) and the parapyramidal region (N=7).
Injections in the commNTS region were centered ~400 μm caudal to the calamus scriptorius. We
included a 5% dilution of fluorescent latex microbeads (Lumafluor, New City, NY) with all drug
applications to mark the injection sites and to verify spread of the injections.

For in vitro experiments, we bath applied suramin (100 µM) to block P2-receptors. In addition, ATP (1
mM in HEPES buffered medium, pH 7.3) was delivered focally using low-resistance pipettes connected
to a Picospritzer III (Parker Instrumentation, Cleveland, OH). Application times were 600 ms, and
vehicle control experiments were performed to ensure agonist responses were not attributable to pressure
artifacts.

Immunohistochemistry
Anesthetized rat pups (p7-12) were perfused with 4% paraformaldehyde (PFA) solution through the left
ventricle. The brain was dissected and fixed overnight at 4°C in 25 ml of 4% PFA. Coronal medullary
slices (50 µm thick) containing the RTN, NTS, and RPa were obtained with a Leica microslicer. Sections
83

were stored in cryogenic glycol solution at -20°C prior to staining. Fixed slices were rinsed three times in
PBS and blocked and permeabilized in PBS solution with 5% normal goat serum (NGS) and 0.5% Triton
X-100. Sections were incubated overnight for two days at 4°C in primary antibodies (mouse antiAldh1L1, 1:1000 dilution) diluted in 5% NGS, 0.5% Triton X-100 and PBS. Sections were rinsed 3 times
in PBS and incubated in secondary antibodies (Cy3-conjugated donkey anti-rabbit IgG, 1:500 dilution;
Alexa 488-conjugated donkey anti-mouse IgG, 1:1000 dilution) diluted in 5% NGS, 0.5% Triton, and
PBS for one hour at room temperature. The slices were mounted using Vectashield with DAPI.

Confocal z-stack images were taken of the RTN, commNTS, and raphe pallidus using a Nikon A1R
confocal microscope with 40x oil immersion objective. Serial z-stacks were taken of both DAPI and alexa
488 channels, to identify nuclei and astrocyte soma a processes. The z-stacks were processed and
analyzed in Image J. Astrocytes were counted by identifying nuclei with greater than 50% surrounded by
Aldh1L1 staining. Volume was determined by measuring the 2-D (x-y plane) area of interest and
multiplying this area by the slice thickness (z stack depth) of 50 µm. Astrocyte cell counts for each slice
(N=4 animals) were normalized to volume.

Statistics
Data are reported as mean ± standard error of the mean. Statistical analysis was performed using Sigma
Stat version 3.0 software (Jandel Corporation, Point Richmond, CA). T-test, paired t-test or one-way
ANOVA followed by the Newman-Keuls multiple comparisons test were performed as appropriate (p <
0.05).

RESULTS
This study is composed of both in vitro and in vivo experiments. In the brain slice preparation, I
determine if purinergic signaling can influence basal activity or CO2/H+-sensitivity of putative
chemoreceptors by testing effects of focal ATP application on firing rate and bath application of a P2
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receptor blocker (suramin or PPADS) on CO2/H+-responsiveness of neurons in the commNTS and
medullary raphe. To provide a functional basis for these results, my collaborators at the University of Sao
Paulo tested in vivo the effects of ATP and PPADS on baseline cardiorespiratory activity and CO2responsivness. As a positive control for ATP injections in the commNTS and raphe, my collaborators
also test effects of focal ATP application into the RTN on breathing and blood pressure. In addition,
considering that astrocytes are the most likely source of CO2/H+-evoked ATP release in the RTN, we
performed a set of immunohistochemical experiments using the astrocyte specific marker aldehyde
dehydrogenase (Aldh1L1) to determine the relative density of astrocytes in the RTN, commNTS and
medullary raphe.

Purinergic signaling in the commNTS increases activity of chemosensitive neurons and respiratory
activity but does not contribute to CO2/H+-responsiveness.
We recorded from CO2/H+-sensitive commNTS neurons in slices to characterize effects of purinergic
signaling on baseline activity and CO2/H+-responsiveness. As previously described (Conrad, Nichols et al.
2009), a neuron was designated CO2/H+-sensitive if it was spontaneously active under control conditions
(5% CO2) and responded to 15% CO2 with a ≥ 0.5 Hz increase in firing rate (this corresponds with a
chemosensitivity index of ~150%). We did not find any CO2-inhibited cells but this is not surprising
considering that only a small minority of cells in this region have been shown to be inhibited by
hypercapnia (Dean, Bayliss et al. 1990). The average firing rate of CO2/H+-sensitive cells was 0.58 ± 0.14
Hz (N = 7) under control condition and 2.06 ± 0.46 Hz in 15% CO2 (i.e., CO2 increased activity 1.49 ±
0.25 Hz, N = 7, Figs. 16A-B). This level of CO2/H+-sensitivity is nearly identical to what has been
described previously for cells in this region (Conrad, Nichols et al. 2009, Dean, Bayliss et al. 1990) so we
are confident that we are recording from the group of cells thought to function as chemoreceptors. To gain
some insight into the neurochemical phenotype of CO2-sensitive commNTS neurons, we filled recorded
cells with biocytin for subsequent immunohistochemical analysis using antibodies for the transcription
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factor Phox2b and choline acetyltranferase (ChAT; marker of cholinergic neurons). We found that 5 of 5
CO2-sensitive commNTS neurons were negative for Phox2b and ChAT (Figs. 16D-G).
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Figure 16
Purinergic signaling modulates activity but not CO2/H+-sensitivity of NTS neurons in vitro. A,
firing rate trace from a commNTS neuron shows that under control conditions exposure to 15% CO2
increased neuronal activity of ~1 Hz in a reversible and repeatable manner. Under control conditions,
focal application of ATP (1 mM) evoked a rapid and robust increase in firing rate of ~ 3 Hz. Bath
application of the P2-receptor blocker suramin (100 µM) had no effect on basal activity but significantly
attenuated the firing rate response to ATP. In the continued presence additional bouts of 15% CO2
increased firing rate by an amout similar to under control conditions. B, summary data (N=5) shows that
suramin had no measurable effect on CO2/H+-sensitivity of commNTS neurons. C, summary data (N=5)
confirms that suramin effectively blunted ATP responsiveness of these neurons. * different from control
(p < 0.05). D-G, biocytin labeled CO2/H+-sensitive commNTS neuron (D, arrow) is immuno-negative for
choline acetyltranferase (ChAT) (E) and phox2b (F), panel G shows merged images of the same cell in
D-F. Each image is the average projection of a confocal stack; around 30 images taken every 0.26 μm in
the Z plane. Scale bar is 20 µm.
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To determine if purinergic signaling contributes to activity of commNTS neurons, we first measured the
firing rate response CO2/H+-sensitive neurons in this region to focal application of ATP (1 mM in HEPES
buffered saline, pH 7.3). Under control conditions all five cells tested exhibited a large reversible and
repeatable increase in activity (increase of 3.38 ± 1.24 Hz, N = 5) in response to ATP (Figs. 16A,C). Bath
application of the P2-receptor blocker suramin had no discernible effect on baseline activity (firing rate
under control conditions and in suramin was 0.58 ± 0.14 and 0.66 ± 0.13 Hz, respectively), suggesting
these cell do not receive purinergic drive under control conditions. As expected, suramin decreased the
firing rate response to ATP by 67.0 ± 7.2% (N = 5), thus confirming that P2-recepotrs are effectively
blocked under these conditions. However, suramin did not blunt the firing rate response to CO2 (firing
rate under control conditions and in suramin was 1.49 ± 0.25 and 1.58 ± 0.28 Hz, respectively) (Figs.
16A-B). This indicates that CO2-sensitive commNTS neurons are activated by purinergic signaling;
however, this signaling mechanism does not contribute to CO2-responsivness of these cells in vitro.

It is possible that endogenous purinergic drive to CO2/H+-sensitive commNTS neurons was disrupted in
our in vitro preparation. Therefore, we also tested effects of commNTS injections of ATP and a P2receptor blocker (PPADS) on baseline breathing and the ventilatory response to CO2 in anesthetized rats.
Consistent with our slice data, we found that injection of ATP (10 mM - 50 nl) into the commNTS
elicited an increase in phrenic nerve amplitude (PNA ampl) by 46 ± 6% and frequency (PNA freq) by 103
± 11%. ATP injections into this region also increased MAP (21 ± 4, vs. saline: 3 ± 1 mmHg, p = 0.0032)
(Figs. 17A-E). Also consistent with our slice data, bilateral injections of a P2-receptor blocker (PPADS;
3 mM - 50 nl; N = 6/group) into the commNTS did not change resting PNA (99 ± 7% of control, p =
0.176) or MAP (124 ± 5 mmHg compared to saline 123 ± 7 mmHg, p = 0.0752) (Fig. 18A). Furthermore,
bilateral PPADS injections into the commNTS did not affect cardiorespiratory response to CO 2; exposure
to 10% CO2 increased PNA amplitude (103 ± 9% vs. saline: 99 ± 13%, p = 0.175), PNA frequency (107
± 6% vs. saline: 105 ± 4%, p = 0.156) and blood pressure (18 ± 7 mmHg vs. saline: 21 ± 4 mmHg, p =
0.136) (Figs. 18A-E).
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Figure 17
Injection of ATP into the commNTS increased breathing and blood pressure in vago-sino-aortic
denervated rats by a P2-receptor dependent mechanism. A, recordings of AP and PNA show that
application of ATP (10 mM, 50 nl) into the commNTS increased breathing and blood pressure when
preceded by injection of saline into this same region (i.e., control condition) but not after injection of
PPADS into this region. Cardiorespiratory responses to ATP partly recovered after washing PPADS for ~
1 hr. B, histology section showing the distribution of fluorescent microbeads within the commNTS. CE, summary data (N=5) show changes in mean arterial pressure (ΔMAP) (C), PND amplitude (ΔPND
ampl) (D) and PND frequency (ΔPND freq) (E) elicited by injection of saline or ATP into the commNTS.
Abbreviations: Gr, gracile nucleus; cc, central canal. Scale bar in B is 100 µm.
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Figure 18
P2-receptor blockade at the level of the commNTS had no effect on hypercapnia-induced changes
in cardiorespiratory activity of anesthetized vago-sino-aortic denervated rats. A, recordings of endexpiratory CO2 (etCO2), arterial pressure (AP) and integrated phrenic nerve activity (iPNA) show the
pressure and ventilatory responses of a rat to hypercapnia under control conditions (i.e., after saline
injection) and 10 min after PPADS (3 mM, 50 nl) was injected into the commNTS. B, computer-assisted
plots of the center of the injection sites revealed by the presence of fluorescent microbeads included in the
injectate (coronal projection on plane Bregma -14.3 mm; (Paxinos, Watson 1982). C-E, summary data
(N=6) show that commNTS injections of PPADS had no effect on CO2-induced changes in mean arterial
pressure (ΔMAP) (C), PND amplitude (ΔPND ampl) (D) and PND frequency (ΔPND freq) (E).
Abbreviations: Gr, gracile nucleus; py, pyramids; Sp5, spinal trigeminal tract; XII, hypoglossal motor
nucleus; cc, central canal. Black dots represent the injections sites in the commNTS.
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For these experiments, injections of ATP or PPADS were centered about 400 μm caudal to the calamus
scriptorius (Fig. 17B and 18B). A single injection of ATP or PPADS was administered in or near the
midline. Based on the distribution of the fluorescent microbeads (Fig. 17B), the injectate spread
bilaterally ~ 500 μm from the injection center and ~300 μm from the injection center in the rostrocaudal
direction.

Purinergic signaling in the medullary raphe does not modulate activity of CO 2-sensitive neurons in
vitro or contribute to the chemoreflex in vivo.
We recorded from CO2/H+-sensitive medullary raphe neurons in slices to characterize effects of
purinergic signaling on baseline activity and CO2-resonsivness. For these experiments we targeted the
raphe pallidus at approximately the same rostrocaudal level as the RTN (-11.6 mm bregma). Cells in this
region were considered CO2/H+-sensitive (activated or inhibited) if they respond to 15% CO2 with ≥ 20%
change in firing rate (this corresponds with a chemosensitivity index of ≥ 120% or ≤ 80%). This criteria
is similar to previous definitions of raphe chemosensitivity (Richerson, 1995; Wang & Richerson, 1999).
It should be noted that cells were presumed to be serotonergic based on i) location, ii) CO2/H+-sensitivity,
and iii) expression of a characteristic serotonin-activated inward potassium conductance (Bayliss et al.,
1997) measured in voltage clamp at the end of each experiment, data not shown). The majority of cells in
this region did not respond to 15% CO2, as expected for raphe neurons in slices isolated from animals ≤
12 days of age (Wang & Richerson, 1999). Raphe neurons that were stimulated by hypercapnia (N=6)
had a spontaneous discharge rate of 0.96 ± 0.26 Hz in 5% CO2 that increased to 1.53 ± 0.33 Hz in 15%
CO2 (Figs. 19A-B). Raphe neurons that were inhibited by hypercapnia (N=3) had a spontaneous firing rat
of 0.70 +/- 0.13 in 5% CO2 that decreased to 0.28 ± 0.06 in 15% CO2 (Figs. 19C-D).

To determine if purinergic signaling contributes to activity of these cells, we next measured
CO2/H+-responsiveness of raphe pallidus neurons when P2 receptors are blocked with suramin. Bath
application of suramin (100 µM) had no measurable effect on baseline activity or CO2/H+-sensitivity of
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Figure 19
Purinergic signaling does not modulate activity or CO2/H+-sensitivity of raphe pallidus neurons in
vitro. A, trace of firing rate from a CO2/H+-activated RPa neuron shows that exposure to 15% CO2
increased firing rate ~0.5 Hz under control conditions and when P2 receptors were blocked with suramin
(100 µM). In addition, focal application of ATP (1 mM) had no effect on neuronal activity (arrow). B,
summary data (N=6) shows that suramin had no effect on the CO2/H+-activated RPa neurons. C, firing
rate trace from a CO2/H+-inhibited RPa neuron shows that exposure to 15% CO2 decreased firing rate by
~ 0.3 Hz under control conditions and during P2 receptor blockade with suramin. Focal application of
ATP (1 mM) had no effect on neuronal activity (arrow). D, summary data (N=3) shows that suramin had
no effect on the CO2/H+-inhibited RPa neurons. // designates 10 min time breaks.
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these cells. For example, in the presence of suramin CO2/H+-activated cells respond to hypercapnia with
an increase in firing rate from 1.12 ± 0.36 Hz to 1.74 ± 0.15 Hz (Figs. 19A-B). This response corresponds
with an activity increase of 0.60 ± 0.15 Hz which is not significantly different from CO 2/H+-induced
increase under control conditions (0.57 ± 0.11 Hz). Similarly, in the presence of suramin CO 2/H+inhibited neurons respond to 15% CO2 with a decrease in firing rate from 0.76 ± 0.12 Hz to 0.39 ± 0.12
Hz (Figs. 19C-D). This corresponds with a 0.39 ± 0.12 Hz decrease in activity which is similar to
CO2/H+-mediated inhibition under control conditions (Figs. 19C-D). Furthermore, in a separate series of
experiments we found that 11 (7 CO2/H+-activated and 6 CO2/H+-inhibited) of 13 CO2/H+-sensitive raphe
pallidus neurons showed no measurable response to focal application of ATP (1 mM in HEPES buffered
saline, pH 7.3) (Figs. 19A-C). Two raphe neurons (one CO2-activated and one CO2-inhibited) responded
to ATP with an increase in firing rate (data not shown). Together, these results indicate that purinergic
signaling does not contribute to CO2/H+-sensing by raphe pallidus neurons in vitro.

To determine if purinergic signaling in the medullary raphe contributes to the whole animal chemoreflex,
we tested effects of medullary raphe injections of ATP and PPADS on baseline breathing and the
ventilatory response to CO2 in urethane-anesthetized rats. For these experiments we targeted the raphe
pallidus (RPa) (N = 6) and the paraparamidal region (Ppy) (N = 5) because serotonergic cells in region
reportedly function as chemoreceptors (Richerson 2004) and they are located within diffusion distance
(estimated to be ~400 µm from the ventral surface (Spyer, Gourine 2009) from sites of CO2/H+-evoked
ATP release on the ventral surface. Injections of PPADS were placed bilaterally in the medullary raphe in
these rats (Fig. 20B). The injection center was 200-230 µm below the facial motor nucleus, 200 µm
rostral to the caudal end of this nucleus and 1 mm lateral to the midline as previously demonstrated
(Mulkey, Stornetta et al. 2004, Takakura, Moreira 2011). Consistent with our in vitro data, we found that
bilateral injections of PPADS (3 mM - 50 nl) into either the RPa or Ppy had no effect on baseline PNA or
the ventilatory response to CO2. For example, bilateral injections of PPADS (3 mM - 50 nl; N = 8/group)
into these did not change resting PNA (101 ± 3% of control, p = 0.246) or MAP (119 ± 3 mmHg
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Figure 20
P2 receptor antagonist injections into the medullary raphe had no effect on hypercapnia-induced
changes in arterial pressure and PNA in vago-sino-aortic denervated rats. A, recordings from one rat
show effects of injection of PPADS into the RPa/Ppy on changes in phrenic nerve activity (PNA) elicited
by an increase of end-expiratory CO2 from 5 to 10%. Responses were recorded 10 min after injection of
saline (50 nl) or PPADS (3 mM, 50 nl) into the RPa/Ppy. B, computer-assisted plot shows the center of
the injection sites (coronal projection on plane Bregma -11.6 mm; (Paxinos, Watson 1982).

C-D,

summary data (N=8) shows that PPADS injection into the RPa/Ppy had no effect on CO2-induced
changes in mean arterial pressure (ΔMAP) (C), PND amplitude (ΔPND ampl) (D) or PND frequency
(ΔPND freq) (E). Abbreviations: py, pyramid; RPa, raphe pallidus; RPpy, raphe parapyramidal ; Sp5,
spinal trigeminal tract; VII, facial motor nucleus. Black dots represent the injections sites in the RPa/Ppy.
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compared to saline 117 ± 4 mmHg, p = 0.234) (Fig. 20A). In addition, bilateral injections of PPADS into
these regions did not affect the hypercapnia-induced increase in PNA amplitude (106 ± 11% vs. saline:
105 ± 14%, p = 0.237), PNA frequency (102 ± 8% vs. saline: 101 ± 5%, p = 0.264), or pressor response
(22 ± 4 mmHg vs. saline: 22 ± 6 mmHg, p = 0.179) (Fig. 20A-E). Also consistent with our slice data, we
found that injections of ATP (10 mM - 50 nl) into the medullary raphe had no effect on PNA ampl, PNA
freq and blood pressure (Figs. 21A-E).

Application of ATP into the RTN increases cardiorespiratory activity
There is strong evidence that purinergic signaling contributes to RTN chemoreception (Gourine, Llaudet
et al. 2005, Gourine, Kasymov et al. 2010, Huckstepp, id Bihi et al. 2010, Wenker, Kreneisz et al. 2010,
Wenker, Sobrinho et al. 2012). We confirm this possibility by testing effects of unilateral injections of
ATP into the RTN on cardiorespiratory activity. These experiments also serve as a positive control for
similar experiments in the commNTS and medullary raphe (described above). Consistent with previous
evidence (Gourine, Llaudet et al. 2005, Mulkey, Mistry et al. 2006), we found that unilateral injection of
ATP into the RTN increased MAP (14 ± 3, vs. saline: 2 ± 3 mmHg, p = 0.034), PNA amplitude by 26 ±
5% and PNA frequency by 21 ± 4% (Fig. 22A-E). These results confirm that purinergic signaling at the
level of the RTN regulates cardiorespiratory activity.

The RTN contains a higher density of protoplasmic astrocytes compared to the cNTS or RPa.
Previous evidence suggests that CO2-evoked ATP release from astrocytes contributes to RTN
chemoreception (Gourine, Kasymov et al. 2010, Huckstepp, id Bihi et al. 2010, Wenker, Kreneisz et al.
2010, Wenker, Sobrinho et al. 2012). In the present study we show that purinergic signaling does not
contribute to chemoreception in the commNTS or medullary raphe. We postulate that the differential role
of purinergic signaling in these regions results from a higher density of astrocytes in the RTN compared
to the commNTS or medullary raphe. To test this possibility, we determine the relative density of
astrocytes by counting the number of
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Figure 21
Injection of ATP into the medullary raphe had no effect on breathing or blood pressure. A,
recordings of AP and PNA show that application of ATP (10 mM, 50 nl) into the medullary raphe
(RPa/Ppy) did not affect blood pressure or respiratory motor output. B, histology section showing the
distribution of fluorescent microbeads within the RPa. C-E, summary data (N=11) show that RPa/Ppy
injections of ATP had no effect on mean arterial pressure (ΔMAP) (C), PND amplitude (ΔPND ampl) (D)
or PND frequency (ΔPND freq) (E). Scale bar in B is 50 µm.
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Figure 22
ATP injections into the RTN increase cardiorespiratory activity. A, recordings of arterial pressure
(AP) and phrenic nerve activity (PNA) show that under control conditions unilateral injection of ATP (10
mM, 50 nl) into the RTN increased breathing and blood pressure. Injection of PPADS (3 mM, 50 nl) into
the RTN blocked cardiorespiratory responses to subsequent applications of ATP. B, computer-assisted
plot and representative histological section show center of injection sites (coronal projection on plane
Bregma -11.6 mm; (Paxinos, Watson 1982)). C-D, summary data (N=6) show changes in mean arterial
pressure (ΔMAP) (B), PND amplitude (ΔPND ampl) (C) and PND frequency (ΔPND freq) (D) elicited by
injection of saline or ATP into the RTN. Abbreviations: py, pyramid; RPa, raphe pallidus; Sp5, spinal
trigeminal tract; VII, facial motor nucleus. Black dots represent the injections sites in the RPa/Ppy. Top
and bottom scale bars in B are 1 mm and 50 µm, respectively.
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Aldh1L1-positive cells in a 1 mm2 section within the regions of interest (see methods for details).
Astrocytes were counted in confocal Z-stack images by identifying DAPI-labeled nuclei with greater than
50% surrounded by Aldh1L1 staining. Images of the RTN were taken in a region located between the
pyramids and trigeminal and directly ventral to the facial motor nucleus at a depth ~100 µm from the
ventral surface (Fig. 23A). Images of the raphe pallidus were taken midline between the pyramids and
near the ventral surface (Fig. 23B). Images of the commNTS were taken medial to the solitary tract in
slices that were ~200 µm caudal to area postrema (-14.04 mm Bregma) (Fig. 23C). We found that the
RTN contained approximately 3 times as many astrocytes as the commNTS or raphe pallidus (Fig. 23D).

DISCUSSION
There is compelling evidence that CO2/H+-evoked ATP release from ventral surface astrocytes
contributes to respiratory drive by activating chemosensitive RTN neurons (Gourine, Llaudet et al. 2005,
Wenker, Sobrinho et al. 2012, Huckstepp, id Bihi et al. 2010). Here, we confirm that activation of P2receptors in the RTN increases cardiorespiratory activity, and we test at the cellular and systems level
whether purinergic signaling also modulates activity or CO2/H+-sensitivity of neurons in two other
brainstem regions thought to contribute to central chemoreception (i.e., the commNTS and medullary
raphe). As expected, application of ATP into the RTN elicited a strong increase in breathing and a mild
increase in blood pressure by a P2-receptor dependent mechanism, thus further supporting the possibility
that purinergic signaling in the ventrolateral medulla can modulate activity of respiratory chemoreceptors
(Gourine, Llaudet et al. 2005, Wenker, Sobrinho et al. 2012, Huckstepp, id Bihi et al. 2010) and blood
pressure regulating C1 cells (Wenker, Sobrinho et al. 2013). Similar to previous evidence in the RTN,
CO2/H+-sensitive commNTS neurons also respond to focal ATP application with a robust increase in
firing rate, and in vivo ATP injection into the commNTS increased breathing. Conversely, CO2/H+sensitive medullary raphe neurons did not respond to ATP nor did injection of ATP into this region elicit
a cardiorespiratory response. Contrary to evidence in the RTN, inhibition of P2-receptors in the
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Figure 23
The RTN has a higher density of astrocytes than the commNTS or RPa. A-C, diagram (right) and
photomicrograph (left) of a transverse medullary slices containing the RTN (A1), RPa (B1) and the
commNTS (C1). Areas labeled in red represent the regions of interest. Red boxes identify regions of
interest where confocal images were taken. A2-C2, projection images of confocal z-stacks of the RTN
(A2), RPa (B2) and NTS (C2), in which the blue channel represents DAPI staining and the green channel
Aldh1L1 immunoreactivity. To be counted, a cell had to have a clearly defined nuclei with bright DAPI
staining as well as bright Aldh1L1 staining around at least half of the nucleus (arrows in each image). D,
summary data (N=4 animals) show the relative astrocyte density in the RTN, RPa and commNTS. Note
that the RTN had a significantly higher astrocyte density compared to the commNTS or RPa (one-way
ANOVA on ranks). These results support the possibility that astrocytes are an important component of
RTN chemoreception.
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commNTS and medullary raphe had no effect on basal activity and CO2/H+-sensitivity in vitro, or
baseline cardiorespiratory activity and CO2-responsivness in vivo. Furthermore, we found that the RTN
contains a higher density of astrocytes compared to the commNTS and raphe pallidus, suggesting that the
unique role of purinergic signaling in the RTN is a consequence of astrocyte density. Therefore, previous
and present results suggest that purinergic signaling is a unique feature of RTN chemoreception.
The RTN is an important sight of chemoreception and intense effort has been made to identify a unique
CO2/H+-sensing mechanism in this region. Evidence indicates that chemosensitive RTN neurons sense
and respond to changes in tissue CO2/H+ directly (Lazarenko, Milner et al. 2009, Onimaru, Ikeda et al.
2012, Wang, Shi et al. 2013), possibly by inhibition of a K+ conductance (Mulkey, Stornetta et al. 2004,
Mulkey, Talley et al. 2007), and indirectly by CO2/H+-evoked ATP release most likely from astrocytes
(Gourine, Llaudet et al. 2005, Wenker, Sobrinho et al. 2012, Huckstepp, id Bihi et al. 2010). The identity
of the neuronal pH-sensor remains unknown and thus precludes further analysis; however, evidence does
suggest that a subset of RTN astrocytes are uniquely specialized to release ATP in a CO 2/H+-dependent
manner. For example, CO2/H+-evoked ATP release has been shown to occur at discrete regions on the
ventral surface near the RTN but not in deeper brainstem regions or near the dorsal surface (Gourine,
Llaudet et al. 2005, Huckstepp, id Bihi et al. 2010). In addition, evidence suggests that a subset of ventral
surface astrocytes but not cortical astrocytes respond to H+ with an increase in intracellular Ca2+ and
vesicular release of ATP (Kasymov, Larina et al. 2013). The results presented here build on the
possibility that purinergic signaling is a unique component of RTN chemoreception by showing that P2recepotr blockade in two putative chemoreceptor regions did not affect CO2-responsivness in vitro or in
vivo. The differential role of purinergic signaling CO2/H+-sensing by cells in these regions may result
from a higher density of astrocytes in the RTN compared to the commNTS and medullary raphe; however
it is also possible that RTN astrocytes are unique and functionally specialized to release ATP during
hypercapnia as previously suggested (Kasymov, Larina et al. 2013).

108

The caudal portion of the NTS is thought to contribute to central chemoreception because a subset of
neurons in this region respond to CO2 with increased firing rate (Conrad, Nichols et al. 2009, Dean,
Bayliss et al. 1990) and focal acidification of this region has been shown to stimulate breathing in
anesthetized and unanesthetized animals (Li, Nattie 2002, Coates, Li et al. 1993). Although the cellular
and molecular identity of CO2/H+-sensors in the commNTS are unknown, it is well established that cells
in this region, including Phox2b immunoreactive neurons (Stornetta, Moreira et al. 2006), relay peripheral
chemosensory inputs to other components of the respiratory circuit; thus cells in this area are well
positioned to regulate cardiorespiratory activity in response to hypercapnia.

Previous evidence suggests that purinergic signaling in the commNTS influences cardiorespiratory
activity. For example, several types of P2-receptors are expressed in the commNTS (Yao, Barden et al.
2000) and injection of ATP or related analogs into the commNTS of awake rats mimicked
cardiorespiratory responses (i.e., bradycardia, hypertension and tachypneia) to peripheral chemoreceptor
activation (Antunes, Braga et al. 2005, de Paula, Antunes et al. 2004, Paton, De Paula et al. 2002).
Purinergic signaling also contributes to pulmonary stretch receptor-mediated activation of second-order
relay neurons in the NTS to control inspiration (Gourine, Dale et al. 2008).

Consistent with the

possibility that purinergic signaling in the commNTS contributes to cardiorespiratory control, we show
that ATP injections into this region increased cardiorespiratory activity. We also show that CO2/H+sensitive commNTS neurons are strongly activated by focal ATP application. It should be noted that the
neurochemical phenotype of CO2/H+-sensitive commNTS neurons remains unknown, since these cells
were immune-negative for Phox2b and ChAT. Nevertheless, blocking P2-recepotrs in this region did not
affect the firing rate response to CO2/H+ in vitro, or the ventilatory response to CO2 in vivo. These results
indicate that purinergic signaling can increase activity of CO2/H+-sensitive commNTS neurons and
stimulate cardiorespiratory activity, but this mechanism does not contribute to CO 2-responsivness. It
remains possible that astrocytes in this region contribute to CO2/H+-responsiveness of commNTS
neurons, albeit by an ATP-independent mechanism.
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For example, recent evidence showed that

acidification decreased glutamate uptake by NTS astrocytes and facilitated gutamatergic slow excitatory
potentials that could potentially increase integrated output of the NTS to the rest of the respiratory
network (Huda, McCrimmon et al. 2013).

Serotonergic medullary raphe neurons can strongly influence breathing (Hodges, Richerson 2010) and
are thought to function as respiratory chemoreceptors in part because neurons in this area have been
shown to be acid sensitive in vitro (Wang, Tiwari et al. 2001, Wang, Pizzonia et al. 1998, Severson,
Wang et al. 2003, Richerson 1995), focal acidification of this region increased breathing in
unanesthetized awake (Hodges, Martino et al. 2004) or sleeping (Nattie, Li 2001) animals, and genetic
deletion (Hodges et al., 2008) or selective inhibition (Ray, Corcoran et al. 2011) of serotonergic neurons
decreased the ventilatory response to CO2. As previously described (Richerson 1995, Wang, Pizzonia et
al. 1998) , we found a subset of medullary raphe neurons in slices from neonatal rat pups that responded
to 15% CO2 with a modest increase or decrease if firing rate.

There is some evidence that CO2/H+-sensitivity of raphe neurons is partially dependent on purinergic
signaling. For example, a study in anesthetized rats showed that microinjection of ATP into the raphe
magnus and pallidus decreased or increased respiratory activity, respectively (Cao, Song 2007). In
addition, injection of PPADS into the medullary raphe blunted the ventilatory response to CO2 of
conscious rats (da Silva, Moraes et al. 2012). Considering that P2-receptors are ubiquitously expressed in
the central nervous system including at the level of the medullary raphe, we were surprised to find that
CO2/H+-sensitive neurons (i.e., activated or inhibited) in the raphe pallidus did not respond to focal
application of ATP in vitro, and injection of ATP into the raphe pallidus or the parapiramidal region had
no effect on baseline breathing in vivo. In addition, blocking P2-receptors in these medullary raphe
regions did not perturb CO2-sensitivity in vitro or in vivo. These results suggest that purinergic signaling
does not influence activity or CO2-sensitivity at these raphe nuclei under our experimental conditions.
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In summary, purinergic signaling contributes to the mechanism by which RTN neurons sense and respond
to changes in CO2/H+; however, this signaling mechanism does not contribute to CO2/H+-sensing in the
commNTS or medullary raphe.

These results are the first evidence for a unique CO 2/H+-sensing

mechanism in the RTN.
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Chapter 7 Summary of Major Findings

Studies from the late 1990’s and early 2000’s indicated that purinergic signaling in the ventrolateral
medulla is required for proper chemoreception (Thomas, Ralevic et al. 1999, Thomas, Spyer 2000,
Gourine, Llaudet et al. 2005). This prompted us to ask the question, what role purinergic signaling plays
in chemoreception at the cellular level? The results of this thesis support a model in which CO 2-evoked
ATP is released from astrocytes via connexin hemichannels to activate RTN neurons and increase
respiratory activity. This provides valuable insight into the fundamental mechanisms of central
chemoreception. This thesis reaches four main conclusions. (1) One mechanism for sensing CO 2/H+ by
astrocytes in by inhibition of Kir4.1-Kir5.1-like channels and the sodium bicarbonate cotrasporter. (2)
Functional purinergic signaling is required for proper chemoreception, both in vivo and in vitro, and CO2,
not pH per se, is the stimulus. (3) The method for ATP release due to CO2/H+ is opening of connexin
hemichannels. (4) The contribution of purinergic signaling to neuronal CO2/H+ sensitivity is restricted to
the RTN/medullary ventral surface. Below, I will discuss these results with respect to the current
literature and propose future experiments to more decisively answer the above questions.

Conclusions
(1) A number of previous reports demonstrate functional Kir4.1 channels in astrocytes of the cortex
(Higashi, Fujita et al. 2001, Olsen, Higashimori et al. 2006, Tang, Taniguchi et al. 2009). These channels
are active at negative potentials and contribute to the very negative membrane potential observed in all
astrocytes. In addition Kir4.1 channels are thought to mediate potassium buffering during high neuronal
activity (Djukic, Casper et al. 2007, Olsen, Sontheimer 2008). Thus, our observation that Kir4.1-Kir5.1
channels are expressed in astrocytes is by no means unexpected. However, it is unusual to find such a
large pH-sensitive conductance in astrocytes. In the hippocampus, more extreme pH solution (compared
to the present study) resulted in only mild inhibition of resting potassium current (Zhou, Xu et al. 2009).
On the other hand, RTN astrocytes decreased membrane conductance by 50% on average. This translates
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to approximately a 10 mV decrease in membrane potential, which is enough to activate voltage gated
channels, including certain connexins (Saez, Retamal et al. 2005). The physiological consequences of this
astrocytic sensing mechanism are not known. Difficulties with pharmacology prevented us for
determining the role of Kir4.1 in chemoreception in vivo. Others have found that congenital KO of Kir5.1
(necessary for physiological pH sensing by Kir4.1) does not affect the central chemoreflex (Trapp, Tucker
et al. 2011). However, the animals suffer from metabolic acidosis, which is intimately entwined with
sensation of blood gases, and thus could offset any slight change to chemosensitivity. To more completely
answer this question it is likely that conditional genetic ablation of Kir4.1 or Kir5.1 is needed (see future
directions).

(2) The most logical mechanism for ATP released at the medullary ventral surface to affect respiratory
output, is for the ATP to activate local respiratory neurons which then relay this information to the proper
respiratory centers. The alternative, diffusion of ATP to the respiratory CPG, seems unlikely, as the
distance is great and ATP would likely be broken down by ectonucleotidases in the process. In addition,
ATP applied to the prebotzinger complex results in a biphasic respiratory response (Lorier, Huxtable et al.
2007), very dissimilar to the response mediated by the central chemoreflex. It was already known that
ATP could increase action potential activity in RTN, but it was also shown that blockade of P2 blockers
had no effect on the pH-sensing of the same neurons (Mulkey, Mistry et al. 2006). In the present study we
found different results when using bicarbonate buffered external solution and decreased pH by elevating
CO2 concentration. RTN neuronal CO2/H+ sensitivity was reduced by ~25% when P2 receptors were
blocked. This effect was independent of external calcium, synaptic input, temperature and stimulus
strength. Independent evidence exists that demontstrates changes in CO2, but not necessarily pH, are
necessary for ATP release (Huckstepp, Eason et al. 2010, Huckstepp, id Bihi et al. 2010), although they
did not assay neuronal function. However, other studies have demonstrated ATP release by altering pH
independent of CO2 (Gourine, Kasymov et al. 2010). In addition, these studies found that in the absence
of functional P2 receptors neurons near the ventral surface lacked CO2/H+ chemosenstivity entirely. The
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reason for the discrepancies between this and the present study is unclear, but a number of experimental
differences are likely the culprit. In Gourine et al., the authors use organotypic slices, as opposed to acute
slices, for whole-cell recordings, as opposed to loose-patch recordings, and use a synthetic Phox2a/b
promoter driving a reporter to identify RTN neurons, as opposed to identification based on CO2/H+sensitivity used in this study. The synthetic promoter is not specific for central chemoreceptor RTN
neurons, with expression being seen in other nearby neurons, including the C1 (Abbott, Stornetta et al.
2009), which could explain the lackluster neuronal chemosensitivity and difference in P2 receptor
function. One thing in agreement between all groups (Huckstepp, id Bihi et al. 2010, Gourine, Kasymov
et al. 2010, Wenker, Sobrinho et al. 2012), is that P2 receptor antagonism in the RTN results in decreased
in vivo chemosensitivity by ~25-30%.

(3) There is consensus that astrocytes in the RTN release ATP, but the mechanism of release is debated
(Gourine, Kasymov et al. 2010, Huckstepp, id Bihi et al. 2010). The two competing hypotheses are (a)
calcium-mediated vesicular release and (b) direct CO2 gating of connexin channels (specifically Cx26)
allowing flux of ATP. In this thesis we assayed for mechanisms of ATP release by using the RTN
neuronal response to CO2/H+ as a readout for ATP release. We found that using a low calcium, high
magnesium, solution to block vesicular release had no effect on CO2/H+ sensitivity of RTN neurons.
However, pharmacological blockade of connexin hemichannels has similar effects on chemosensitivity as
did P2 receptor antagonists. In addition, simultaneous antagonism of connexins and P2 receptors had the
same effect as either one alone, indicating they are both involved in the same signaling pathway. Once
again, our data best supports that of Huckstepp et al. (2010), but does not sync well with work by Gourine
et al (2010). Possible explanation for these discrepancies are the same as described above in conclusion
(2), and likely the different findings related to purinergic signaling’s mechanism of release, effect on
neuronal chemosensitivity and molecule sensed (i.e. H+ versus CO2) are all related.
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(4) Initial experiments found ATP released in vivo due to hypercapnia was restricted regionally to ventral
surface of the medulla (Gourine, Llaudet et al. 2005). In horizontal brain slices, Huckstepp et al. (2010)
also observed ATP release was restricted somewhat in the lateral direction, but also noted that slices
dorsal to the first slice did not exhibit any ATP release during hypercapnia. This prompted us to wonder
whether purinergic signaling is a mechanism of CO2/H+ sensing that is specific to RTN neurons. The
search for specific sensing mechanisms is not new (Guyenet, Stornetta et al. 2008). In line with previous
studies, we found that purinergic signaling is restricted to RTN neurons. Neither medullary raphe nor
cNTS chemosensitive neurons rely on P2 receptors for their CO2/H+ sensing abilities. For cNTS neurons,
this is in spite of the fact that they do express functional P2 receptors. Interestingly, we did not detect
functional P2 receptor expression in Raphe neurons. These data provide evidence that purinergic
signaling involvement in central chemoreception is restricted to the RTN.

Future studies
The bulk of the experiments in this thesis rely on pharmacological manipulations. As I was once told, “A
drug seems to lose its specificity with age.” This is not advice against keeping a drug in storage for an
extended period of time, but it points out that the specificity of a pharmacological agent tends to lessen as
we learn more about the agent. Lack of specificity aside, using pharmacology to study astrocytes is
problematic. Astrocytes are cells just like neurons. They express many of the same channels and
receptors, use calcium as an intracellular signaling mechanism and can release transmitters to affect other
glial cells and neurons (Kimelberg 2010). Any attempt to use pharmacology to antagonize a mechanism
in astrocytes will simultaneous antagonize the same mechanism in neurons, making it impossible to
dissect which cells are responsible for an action. In the present study we do our best to work around this
but it is inevitable. Future studies should utilize conditional genetic approaches (e.g. GFAP-cre
expressing mice, or targeted virus mediated infection) to affect astrocytes selectively. Logical next steps
would include astrocyte specific knock out of genes that encode for Kir4.1, Kir5.1, Cx26, IP3 receptors
and astrocyte SNARE proteins. Some of these genetic tools have been very useful in the Cortex (Djukic,
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Casper et al. 2007, Petravicz, Fiacco et al. 2008, Pascual, Casper et al. 2005). The same can be said for
neurons. This thesis has provided evidence that RTN neurons express functional P2Y receptors. However,
the molecular identity (i.e. receptor subtype) has been difficult to determine (results not shown). This may
be best determined using similar conditional genetic manipulations in neurons. Although no system is
perfect, tools for relatively specific targeting to RTN neurons exist that could allow for targeted
antagonism of specific P2Y receptor subtypes. Let us also not forget that ~75% of RTN neuronal
chemosensitivity appears to be intrinsic, with evidence of a background pH-sensitive potassium channel.
Identification of this channel(s) and its sensing mechanism are necessary for complete understanding of
RTN chemoreception. Once these precise mechanisms can be targeted efficiently we may be able know
the exact mechanism of central chemoreception in a behaving animal.
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